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The pancreas is a glandular organ in the abdomen, partly insulated by the peritoneum, that comprises 
an exocrine part (for excretion of digestive juices into the duodenum) and an endocrine part 
(secretion of hormones into the bloodstream), both have distinct functions, however, both can be 
affected by malignant transformation. The most common cancer of the pancreas is the pancreatic 
ductal adenocarcinoma (PDAC), which is characterised by moderately- to poorly- differentiated 
glandular exocrine structures (Thiruvengadam M. et al., 2013). These neoplasms are often referred 
to as PDAC’s, whereas the terms PET’s and PNET’s indicate pancreatic endocrine tumours and 
pancreatic neuro-endocrine tumours which are generally rare (Benson AB. et al., 2013; Yao JC. et al., 
2007). 
 
Amongst risk factors that might facilitate hypertrophy and resulting malignant transformation of 
pancreatic tissue are: excessive consumption of animal fats (and resulting obesity), lack of exercise, 
and consumption of alcohol and tobacco (Thiruvengadam M. et al., 2013). Epidemiological studies 
showed that consumption of whole grains, fruits and vegetables is inversely proportional to the risk 
of developing pancreatic cancer (Hendrix MJC., 2007; Li L. and Leung PS., 2014). Hypertrophy is 
caused by the hyperactivity the pancreas has to show in order to produce enough enzymes to digest 
the lipids from the food in the duodenum (Pericleous M. et al., 2014). Signalling from adipose tissue 
and feedback loops with insulin and insulin-like growth factor are common events in obese people 
and were suggested to play major roles in the onset and progression of pancreatic cancer (Aleman 
JO. et al., 2014). Several genes, for example BRCA2 (breast cancer 2) (Klein A., 2013), were identified 
that were responsible for familial pancreatic cancer susceptibility, which also plays a major role in 
malignancies of the mammary glands. 
 
Clinical presentation of patients with pancreatic cancer occurs relatively late in the course of the 
disease, since physical complaints arise in a late stage of the disease. In most cases, cells have already 
disseminated throughout the human body where they can form micro-metastases. If a patient 
presents himself before the onset of metastatic disease with an exocrine neoplasm, surgery can be 
applied in some cases (approximately 20 % of the patients are diagnosed with a localized tumour) 
although the complex positioning of the pancreas often prevents tumour resection (Corbo V. et al., 
2012). In 2012, pancreatic cancer caused 330,000 deaths globally, and it is the seventh most common 
cause of deaths due to cancer ("Pancreatic Cancer Treatment (PDQ®) Patient Version". National 
Cancer Institute. 17 April 2014. Retrieved 8 June 2014). 
 
Pancreatitis was suggested to be one of the risk factors for pancreatic cancer too. This can be 




thereby creating a suitable environment for malignancies to develop. Both the innate and adaptive 
immune system are activated in cancer. However, cancer cells induce immune dysfuction by 
secreting immune-suppressors such as transforming growth factor (TGF), or vascular endothelial 
growth factor (VEGF). Additionally, cancer cells have the capability to interfere with MHC class I so 
that transformed cells are no longer recognized by the immune system (Sideras K. et al., 2014). 
Furthermore, pancreatic adenocarcinomas express and secrete tumour antigens which can recruit 
the immune system in some cases so that it will eliminate the tumour cells (Bazhin AV., 2014). 
Release of molecules (such as VEGF) by macrophages in the stroma or colony stimulating factor 1 
(CSF 1) by the tumour itself) can result in a better micro environment for the tumour; these small 
(signalling) molecules can aid in attraction of the vasculature which can supply the tumour with more 
oxygen. This event can be triggered by hypoxia which occurs when the tumour is too large to depend 
on diffusion for its nutrient and gas exchange in the tumour (Wang W., et al., 2007; Bertout J. et al., 
2008 ). Additionally, pancreatic tumour cells were observed to have acquired the ability to thrive on 
lactate metabolism, which enables them to survive in hypoxic conditions. These new properties were 











Figure 1: Transitions between epithelial and mesenchymal states during carcinoma progression. The cell’s 
morphology changes from cubic to elongated and the cell loses its polarity whereas the capability of migration 




Epithelial Mesenchymal Transition (EMT) is a process that occurs when cancer stem cells are formed 
from epithelial cells. Epithelia contain a high level of integrity when healthy, however, when epithelial 
cells transform into mesenchymal cells (Figure 1) they lose their highly specialized properties and 
become able to invade surrounding tissues (World Cancer Report 2014. World Health Organization. 
2014. pp. Chapter 5.7. ISBN 9283204298). Mesenchymal cells are motile and able to 
break loose from the rigid epithelial monolayers. Cell-cell and cell-matrix contacts are broken leading 
to a loss of adhesion and cell polarity are lost and contact inhibition as well as loss of contact with the 
extracellular matrix occurs when an EMT occurs. These metastatic properties were postulated to 
occur very early during tumour progression and were implicated to develop from signals from the 
tumour micro-environment. These signals, if they last long enough, will make the cell adapt (e.g. 









Figure 2: Tumour cell-induced angiogenesis. In this process new blood vessels are formed out of existing nearby 
vessels to supply the tumour with nutrients and oxygen. This occurs by sprouting and branching in response to 
platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and other molecules. (This 







Tumour cell-induced angiogenesis (Figure 2) is a malignant process in which nearby vasculature is 
attracted to the tumour in order to meet the oxygen demand of the tumour. This vascular network, 
together with the lymphatic network which is also hijacked by the tumour is at the same time a 
transport medium for detached tumour cells which are capable of spreading to other sites in the 
human body to form a secondary mass (Wang W., et al., 2007). Invasion can take place after EMT has 
started. Since the transformed malignant cells have acquired the ability to move, they will extend 
their population into neighbouring tissues, travel in the bloodstream and settle at a distant site where 






Figure 3: Metastatic events during tumour progression. By multiple signaling pathways and acquired mutations, 
malignant cells adapt to extra-vasate and survive in distant sites to form new micro-metastic cell masses. (This 







When searching for an option to reverse or neutralize the events caused by genetic mutations, 
identification of the genes involved is essential. Many gene products are currently identified as 
factors that can affect tumour-progression. Genes involved in the development and patterning of an 
embryo were implicated too in the context of malignancies. HOX (homeobox) genes which are 
involved in cell destination, patterning and migration (Durston AJ., 2012), could play a role in 
metastasis and angiogenesis since the growth of a tumour could be seen as a developmental process. 
Another group of genes are important for invasion and metastasis: genes that regulate cell motility 
by remodelling the actin cytoskeleton, which is subsequently suitable for movements (Wang W., et 
 




metalloproteins and integrins, or by up-regulation of proteins that control remodelling of the actin 
cytoskeleton, such as the Limkinases or members of the small GTP-ases like Rho and Rac (Croft DR. 
and Olson MF., 2006). 
 
Also, the extracellular matrix is broken down, because a transformed cell has altered lysosomes that 
are capable of digesting it. In some cancer cells lysosomes are bigger and more centred in the cell, 
additionally, the integrity of their membranes has decreased, so that they can spill their contents into 
the cell and subsequently into the extracellular matrix (ECM). Conversely, when the autophagocytic 
pathway is blocked in a cell, the cell will undergo apoptosis as a self-protective mechanism (Kroemer 








Cell lines studied in this work 
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Animal model and platforms used in this thesis 
 
The zebrafish emerged as an in vivo cancer model to study both tumour-induced neovascularization 
and the formation of micro-metastases of xeno-transplanted cancer cells and tumour fragments. In 
the transparent zebrafish embryos, invasion and migration of tumour cells, their circulation in the 
vascular system, as well as the formation of micro-metastasis and the tumour-induced 
neovascularization can all be followed with high resolution in real-time. Importantly, these zebrafish 
models allow to quantitate both metastatic behaviour of transplanted tumour cells and tumour-cell 
induced neovascularization, as was described in detail before (Marques I., et al, 2009; Nicoli S. et al 
2008; Nicoli S. and Presta M., 2007). Tg(fli1:eGFP) zebrafish embryos were used for the studies in this 
 
thesis because they express EGFP in their vascular endothelial cells. 
 
The platforms that were used to test malignant properties comprised of two pancreatic 
adenocarcinoma cell lines and a set of two cell lines derived from two separate secondary sites, 
which originated from the same primary tumour (Table 1). PaTu 8988t cells were observed to be very 
 
aggressive and these cells disseminated readily upon transplantation ectopically of the zebrafish 
embryo as well as in in vitro migration assays, whereas it counterpart, PaTu 8988s cells did not. 
However, all cell lines tested showed the ability to induce angiogenesis. As can be anticipated, there 







This work forms an assessment and a comparison of factors that influence or can influence malignant 
processes, such as metastasis (Figure 3) and angiogenesis, in the background of pancreatic cancer. 
Two approaches were employed, in order to obtain a broad dataset of information regarding the 
behaviour of pancreatic tumour cells under different conditions. Genetic input, both inhibition and 
facilitation of malignant behaviour, was determined for the 39 HOX genes and the two Lim kinases. 








This work was performed using the animal and human cell line platforms and the in vivo zebrafish 




8988s cells were derived from a metastatic foci in the liver belonging to the same primary pancreatic 
tumour. PaTu 8988t showed the ability to migrate in an aggressive manner both in vitro and in vivo, 
while PaTu 8988s cells do not. 
 
HOX genes are essential to axial patterning, they have many essential functions during embryonic 
development including cell migration and are highly conserved amongst species and in time. 
Whether individual HOX genes play a role in metastasis or angiogenesis of pancreatic tumour cells 
was studied and described in chapter 2. All 39 HOX genes were investigated by means of in vitro and 
in vivo assays using zebra fish embryos. Not all HOX genes were observed to be involved in 
metastasis or angiogenesis. Loss of HOX genes from paralogue groups 10-13 were found to facilitate 
malignant processes whereas loss of HOX genes from the lower paralogue groups mostly seemed to 
inhibit metastasis or angiogenesis. 
 
Chapter 3 describes the influence of LIM kinase 1 and – 2 on pancreatic tumour cells using cell 
migration, angiogenesis and metastasis assays. These assays were performed by silencing LIMK1 and 
-2 mRNA with addition of si-RNA (small interference RNA) against LIMK1 and -2 to the cells two days 
before assessment. The results showed that both kinases play a facilitating role in metastasis and 
angiogenesis of pancreatic cancer cells. These molecules are involved with the formation of actin 
fibers and function in motility. One of the results was that knocking down both kinases, completely 
abolished malignant processes in pancreatic tumour cells. 
 
Chapter 4 is based on a drug-screen for candidate chemotherapeutic compounds and their effect on 
angiogenesis and neovascularization, induced in pancreatic cancer cells and in zebrafish embryos, 
respectively. In this study, the compound Iridium and its effects were characterized. As is shown in 
Chapter 4, Iridium complexes are able to inhibit carcinogenic processes if applied in the suitable 
therapeutic window. Also, if tested on zebrafish embryos, it is clear that the embryonic development 
of its own vasculature is inhibited. If the administered dose is too high, severe adverse effects can 
occur. Also, the vehicle in which the drug is suspended has pathological effects when administered in 
a high concentration. The results show that this compound is a serious candidate for an anti- 
metastasis drug; however, administration routes should be subjected to further investigation as well 
as the extent of the therapeutic window in humans. 
 
Chapter 5 provides more insight in the effects of whole snake venoms and candidate therapeutic 
applications of these. From the experiments that are described in the fifth chapter it becomes clear 
that some snake venoms have inhibitory effects on metastasis and angiogenesis of pancreatic cancer 
cells in an in vivo system. In this study, a different method was used in the in vivo model than the 




however no effects were observed. Then, venoms were added to the water which the fish resided in 
(as is done in vascularization assays). In this setting anti-malignant effects became evident for 
venoms derived from cobras (Naja species). 
 
Finally, in chapter 6, the results are placed in context to the real situation, which underlines the 







With a rising incidence of pancreatic cancer during the last decades, public demand for therapeutics 
continues to be strong. Public awareness and knowledge regarding malignancies of the pancreas are 
low. Additionally, scientific understanding also does improve significantly, and the expected resulting 
reduction of the incidence and prevalence of this disease remain cumbersome, in contrast with the 
strong progress made in the treatment of other cancer types such as mammary cancer. 
 
This is especially striking since the overall survival time of pancreatic cancer is very short for patients. 
For these reasons, it is of major importance to identify essential properties and elucidate 
mechanisms of pancreatic cancer progression which are responsible for the poor prognosis for 
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Chapter 2: The oncogenic potential of HOX genes in pancreatic cancer cell 











HOX genes belong to the conserved super family of homeodomain-containing transcription factors 
and play fundamental roles in morphogenesis, organogenesis and differentiation. In vertebrates, 
increasing evidence suggests that HOX genes play a role in cancer progression. The oncogenic 
potential of HOX genes in certain human cancers has been described, but their role in most cancer 
types is still elusive. In this study, the contribution of the human HOX genes to metastatic behaviour 
and tumour-cell induced angiogenesis of four human pancreatic cancer cell lines (PaTu 8988t, PaTu 
8988s, AsPC-1 and Panc-1) was assessed. 
 
Initially, expression of the 39 human HOX genes in the studied cell lines was confirmed. Subsequently, 
their roles in the four pancreatic cancer cell lines were compared using using siRNAs for targeted gene 
silencing. The gene-specific siRNAs were added to the cells for specific genetic silencing and 
subsequent knock down effects were screened for altered migration in vitro and metastatic behaviour 
and tumour cell-induced angiogenesis in vivo. We show here that HOX genes of the paralogue groups 
9 and 10 have a significant effect on pancreatic cancer cell behaviour. Furthermore HOXA2, HOXA5, 
HOXA7 and HOXB8 are shown here to have profound effects on the malignant behaviour of the 






Tumourigenesis and tumour-progression involve interactions of cancer cells with each other, 
neighbouring cells and their microenvironments (Wang W. et al, 2007; Hannahan D. and Weinberg 
RA., 2000; Murdoch C. et al., 2008). Cancer cells often induce surrounding endothelial cells to build 
new vessels as a response to VEGF signalling by the vasculature in order to balance the blood supply 
with the demands of a growing tumour (Goel HL. and Mercurio AM., 2013). The vascular network is 
further employed by metastasizing cancer cells for their long and short distance traveling (Cao Y., 
2005). The complex mechanisms that regulate these “nomadic” cancer cells include intravasation and 
extravasation. To successfully form a micro-metastasis, cancer cells need to use the vasculature for 
their transport (Fiedler IJ., 2003). The importance to understand and prevent metastasis formation is 
underlined by the fact that over 90% of all cancer related deaths are due to secondary tumours 
arising from metastasizing cancer cells (Jemal A., 2007). This is especially true for pancreatic cancer 
types which have a poor prognosis in 85-90% of the patients due to metastatic complications (Ganeh 
P. et al, 2007). The 5-year survival is estimated at 5% (WHO, 2014) and pancreatic cancer is 
responsible for 6% of cancer deaths each year (Jemal A., 2007). 
 
Links between HOX gene expression and malignant transformation have been investigated based on 
the rationale that Hox expression in cancer cells is considered to reflect re-emergence of embryonic 
cell behaviour (Shah N., and Sukumar S., 2010). It is widely accepted that the processes of normal 
embryogenesis and neoplasia share many of the same pathways, and that tumour development is an 
aberrant form of organogenesis (Htuchin ME. et al., 2005; Hendrix MJC. et al., 2007). 
 
The oncogenic potential of HOX genes has clearly been implicated in several human cancer types 
(Shah N. and Sukumar S., 2010). For example, HOX genes were shown to play a role in regulating 
lineage determination and maturation in hematopoietic tissues (Mahdipour E. and Mace KA., 2011; 
Magli MC., 1997) and a linkage to increased HOX gene expression was shown in acute leukaemia’s 
(Kongsuwan K. et al., 1988; Alharbi RA., 2013). 
 
The zebrafish has become an in vivo cancer model that allows us to study both tumour-induced 
angiogenesis (Nicoli S. and Presta M., 2007; Nicoli S. and Ribatti D., 2007) and the formation of micro- 
metastases of xeno-transplanted cancer cells (Haldi M., 2006) and tumour fragments (Marques I, 
2009). In the transparent zebrafish embryos, invasion and migration of tumour cells, their circulation 
in the vascular system, as well as the formation of micro-metastases and the tumour-induced 
angiogenesis can be followed with high resolution in real-time (Marques I, 2009). Importantly, these 
zebrafish models allow to quantitate both metastatic behaviour of transplanted tumour cells and 




study, two in vivo zebrafish models were used to characterize and compare the involvement of the 
human HOX genes in tumourigenesis of human pancreatic cancer cells. HOX genes are members of 
the Homeobox gene family. These genes code for transcription factors controlling morphogenesis, 
organogenesis, differentiation and regulate specification of positional identity in vertebrates. HOX 
genes are homeobox-containing genes. They code for transcription factors that help regulate 
morphogenesis, organogenesis, differentiation and positional specification in metazoans (Krumlauf R. 
and McGinnis W., 1992; Pearson JC. et al., 2005). 
 
In humans, HOX genes are located in four clusters (A-D) which consist of a total of 39 genes, assigned 
to 13 paralogue groups based on their sequence similarity. Clusters A-D are located on different 
chromosomes, 7p15, 17p21, 12q13, and 2q31, respectively (Bayley WJ., 1997). Temporal and spatial 
control of HOX gene expression is essential for correct developmental patterning in many animals 
(Durston AJ. et al., 2012; Duboule D. 1994). Regulation of embryonic segmentation and the formation 
of the antero-posterior axis involve cell motility, morphogenesis, division, differentiation and 
apoptosis. These processes have prominent roles in tumourigenesis and –progression (Hannahan D. 
and Weinberg R.A., 2000). 
 
Because of the redundancy of genes that belong to the same paralogue groups, all 39 genes of the 
four clusters were screened for metastatic behaviour and tumour induced angiogenesis. Expression of 
HOX RNA was assessed using PCR in the four cell lines. Then, HOX genes were knocked down using 
siRNA and these cells were subsequently used in an in vitro migration assay, an in vivo metastasis 
assay and in an in vivo angiogenesis assay. Using the results obtained, an estimation can be made 




Materials and Methods 
 
Animal care and handling 
 
Tg(fli1:eGFP) zebrafish were kept at 28° C in tanks with day/night light cycles of 10 hours dark 
alternated with 14 hours light. The zebrafish were handled in compliance with Dutch animal care 
regulations and standard operating procedures. Zebrafish eggs were harvested at two hours post 
fertilization (hpf), followed by incubation at 28° C in egg water (sea salt, 60µg/ml in tap water). The 





All cell lines (PaTu 8988t, PaTu 8988s, PANC-1 and AsPC-1) were cultured at a temperature of 370 C 
and a CO2 pressure of 5%.The PaTu 8988t cell line and the PaTu 8988s cell line were isolated from 
liver metastases over a decade ago (Elsässer HP., 1992). Their behaviour in an in vitro wound healing 
assay and in an in vivo zebrafish xenotransplantation assay were described in detail before (Marques 
I., 2009). PaTu 8988t and PaTu 8988s cells were cultured in DMEM (Gibco) high glucose 
supplemented with 10% FCS (Gibco). AsPC-1 cells (ATCC® (American Tissue and Culture Collection) 
CRL-1682™), first cultured 30 years ago, derived from the metastatic site (ascites) of a pancreatic 
adenocarcinoma. (Chen WH. et al., 1988) were cultured in RPMI (Gibco) with 10% FCS. PANC-1 
(ATCC® CRL-1469™), first described in 1975, originated from an epithelioid carcinoma of the 
pancreatic duct. (Lieber MJ., 1975) were cultured in RPMI with 15% FCS. 
 
PCR and gene silencing using siRNA 
 
SiRNA polynucleotides for silencing the HOX genes and the corresponding primer pairs, were 
purchased from Santa Cruz Biotechnology (HOXA1 siRNA (h) sc-35583, HOXA2 siRNA (h) sc-38673, 
HOXA3 siRNA (h) sc-38675, HOXA4 siRNA (h) sc-75277, HOXA5 siRNA (h) sc-38678, HOXA6 siRNA (h) 
sc-89444, HOXA7 siRNA (h) sc-38680, HOXA9 siRNA (h) sc-38682, HOXA10 siRNA (h) sc-38684, 
HOXA11 siRNA (h) sc-60802, HOXA13 siRNA (h) sc-45666, HOXB1 siRNA (h) sc-38686, HOXB2 siRNA 
(h) sc-38688, HOXB3 siRNA (h) sc-38690, HOXB4 siRNA (h) sc-38692, HOXB5 siRNA (h) sc-75279, 
HOXB6 siRNA (h) sc-38694, HOXB7 siRNA (h) sc-45835, HOXB8 siRNA (h) sc-75281, HOXB9 siRNA (h) 
sc-45669, HOXB13 siRNA (h) sc-43851, HOXC4 siRNA (h) sc-60804, HOXC5 siRNA (h) sc-75287, HOXC6 
siRNA (h) sc-45673, HOXC8 siRNA (h) sc-60806, HOXC9 siRNA (h) sc-75289, HOXC10 siRNA (h) sc- 
44810, HOXC11 siRNA (h) sc-75283, HOXC12 siRNA (h) sc-95877, HOXC12 siRNA (m) sc-146071, D1 
siRNA (h) sc-38696, HOXD3 siRNA (h) sc-38698, HOXD4 siRNA (h) sc-75295 HOXD8 siRNA (h) sc- 




siRNA (h) sc-75293, HOXD13 siRNA (h) sc-45656)). SiRNA and control siRNA were used in a final 
concentration of 50 nM and subsequently delivered into the pancreatic cancer cell lines using 
EndoPorter™ (Gene Tools, LLC). The control siRNA contains a scrambled sequence that will not lead 
to the specific degradation of any known cellular mRNA. The efficiencies of the HOX siRNAs and HOX 
expression in the used cells were tested by RT-PCR, which was described previously including total 
RNA preparation (van der Meer DLM., 2006). The annealing temperature was set to 55° C and the 
extension temperature to 72° C. 
 
In vitro migration assay 
 
The in vitro migration assay was carried out as was previously described (Liang CC., 2007). Cells were 
grown to confluence in 6-well plates (Greiner). Then, the monolayer was scraped along a straight line 
with a 200 µl pipette tip. Pictures of the scratch were taken under a Leica stereomicroscope at 0h, 





Cells were plated in 24-well plates (Greiner) at a seeding density of 4,0 *104 cells and incubated for 
 
48 hours at 370 C and 5% CO2. SiRNA and EndoPorter® (Gene Tools, LLC) were added according to 
manufacturers’ protocol, and the cells were incubated again at 370 C and 5% CO2 for 24 hours. After 
detaching the cells with trypsin (Gibco), two washing steps were done with DPBS (Dulbecco’s PBS, 
Gibco), after which the cells were transferred to 1.5 ml Eppendorf tubes and centrifuged 5 min, at 
1500 rpm. Then, the cells were stained according to manufacturer’s protocol after which the cells 
 
were suspended in 25 μl DPBS for injection into the embryos. 
 
Cell transplantation into zebrafish embryos 
 
After dechorionation, 2 dpf zebrafish embryos were anesthetised with Tricaine methanesulfonate 
(TMS, MS-222, Sigma). Using a manual injector (Eppendorf, Celltram), the cell suspension was loaded 
into an injection needle (15 μm internal- and 18 μm external-diameter (Oxford Apparatus) and cells 
were injected in 48 hpf Tg(fli1:eGFP) zebrafish embryos. After injection, the embryos were incubated 
at 35o C and checked for cell presence at 2 hours post transplantation (hpt). Embryos with 
fluorescent cells outside the implantation area at 24 hpt were excluded from further analysis. All 
 
other embryos were incubated at 35° C for analysis during the following days. Two independent 
experiments are combined for each treatment and cell type (Table 2). Every experiment consisted of 
50 injected and approved embryos. For statistical analysis, a student t-test was performed which 




Tumour cell-induced angiogenesis 
 
The tumour-cell induced angiogenesis assay was in general performed as previously described (Nicoli 
S., Presta M., 2007; Nicoli S., Ribatti D., 2007).The 48 hpf zebrafish embryos were dechorionated and 
anesthetised using 0.042 mg/ mL Tricaine (Sigma). Then, the embryos were positioned on a 1. 8% 
agarose dish for injections. Cells were stained as described above, then suspended in 20 µl 12. 0 mg / 
ml Matrigel® solution (Cultrex R Basement Membrane Extract, R&D systems, Minneapolis, USA) and 
kept on ice for a short period until injection. The CellTram Oil injector (Eppendorf, Germany) was 
loaded with an injection capillary (Harvard apparatus) which was filled with 5 µl of the cell 
suspension in Matrigel®, and embryos were injected as described in more detail in previous studies 
 
(Nicoli S., Protocols 2007; Nicoli S., Cancer Res 2007; Vlecken DH. and Bagowski CP., 2009). Every 
experiment consisted of 50 injected and approved embryos. For statistical analysis, a student t-test 




After injection, embryos were incubated in egg-water at 35°C for 24 hours before screening. Embryos 
were photographed using a Bio-rad confocal microscope equipped with a 1024ES lens (Zeiss) and a 
Krypton/Argon laser. For light-microscopy images of pancreatic cells, an MZ16FA stereomicroscope 
(Leica) and a DFC 420C camera (Leica) were used. The data obtained were processed using ImageJ 






Human HOX genes are expressed in pancreatic cancer cells 
 
The four pancreatic cancer cell lines were subjected to PCR to obtain information regarding HOX 
gene expression (Table 1 and Supplemental Table 1). From this data set it is clear that most HOX 
genes are expressed in the pancreatic cancer cell lines; HOXD4, HOXD8, HOXD9 and HOXD13 were 
not detected in any of the cell lines. As an internal assay control, GAPDH expression was analysed by 









































































), A3 and 
 
A5 
 B6, B13 B2, B8, 
 
B9 

































 D10 D10 [D9, D11]   D10 
HOX genes shown in italic were observed to induce a malignant feature. The genes that reduced 






HOX genes affect pancreatic cancer cell migration in vitro 
 
Despite their well-documented role in regulation of morphogenesis and development in vertebrate 
and non-vertebrate species limited information is available on the function of HOX genes in cell 





















































Figure 1a: An in vitro migration assay ('scratch assay') shows differences in migration of PaTu 8988t cells 




were representative for the other HOX genes that show an effect. In pictures A, C and E, the gap is 
photographed immediately after application of the scratch. In pictures B, D and F, the same area is 
photographed after 48 hours. 
 
 
Gene specific siRNAs were used to individually silence all 39 human HOX genes in PaTu 8988t cell 
line. The results of the in vitro migration assay using PaTu 8988t cells showed that knock down of 
HOXA1, HOXA2, HOXA10, HOXB2, HOXB8, HOXB9, HOXC9, HOXC10, HOXD8, HOXD9 and HOXD10 
had a negative effect on in vitro migration and led to a decrease in gap closure (Figure 1). These 
observations suggest a role for these HOX genes in invasion or migration of pancreatic cancer cells. 
 
HOX genes are involved in metastatic behaviour of pancreatic cancer cells in vivo 
 
To study the role of the human HOX genes in metastatic behaviour, four pancreatic tumour cell lines 
were labelled with a carbocyanine dye (CM-Dil) and ectopically transplanted in the yolk sac of 2 dpf 
zebrafish embryos of the transgenic zebrafish line, Tg(fli1:eGFP), which express GFP under the fli1 
promotor (an early endothelial marker) and therefore exhibit a green fluorescent vasculature 
(Lawson N.D. and Weinstein B.M., 2002). Gene specific and control siRNAs were used to individually 






















































Figure 1b: Gap closure in the migration assay. Gap closure (gap width) over time is shown in percentages 
compared to the 0h time point (set to 100%). Error bars show standard deviations between three independent 
experiments. 
The results (Table 1 and Figure 2a and b) showed that several HOX genes play important roles in 
metastatic behaviour either positive or negative. HOXA2, HOXA7, HOXA9, HOXB9, HOXC9 knock 
downs led to a decrease of metastatic behaviour in all three aggressive cell lines whereas gene 
silencing of HOXA4, HOXB1, HOXB3, HOXC5 and HOXC13 had a positive effect and led to an increase 
of metastatic behaviour in PaTu 8988s cells, AsPc-1 showed similar effects for HOXB1,HOXB3, 
HOXC10 and HOXC13. 
 
The results differed to those obtained with the in vitro migration assay using PaTu 8990t cells (Figure 
 
1). However, in contrast to the in vitro migration assay where many knock downs had no additional 
inhibitory effect, metastatic behaviour in the zebrafish in vivo model (Figure 2) was completely 
abolished by an additional set of siRNA knock downs. As observed in an earlier study, the findings 
indicated significant qualitative and quantitative differences between the two assays and they 
demonstrate an important role for several additional HOX genes in metastatic behaviour of 









Figure 2: The zebrafish tumour xenograft metastasis assay. Shown are representative pictures taken by 
confocal microscopy of xeno transplanted. PaTu 8988t cells either treated with the control siRNA (A and C) or 
treated with the HOX siRNAs (A7 and B7). The pictures show zebrafish embryos 24 hours after transplantation 
(3 dpf, A, B) and 48 hours post transplantation (5dpf, C,D). In the controls, cancer cells have invaded the 
embryo and migrated to distant site. This behaviour is blocked by the HOX siRNAs. The area showing many cells 
with migration behaviour an enlargement is shown (fish B) and here, cancer cells are visible in the vasculature. 







Figure 3: Effects of HOX A2 on angiogenesis in response to tumour cells. 
 
All pictures show PaTu 8990t cells implanted in Tg(:Fli) Danio Rerio 36hpf embryos. In Figures A and B similar 
numbers of cells were injected. Untreated control cells (A and C) cause vessel formation towards the implant. 
Cells treated with HOXA2 siRNA (and cells treated with siRNAs against other HOX genes showing similar effects 
listed in Table 1 ) show inhibition of vessel attraction when implanted in zebrafish embryos. In photos C and D, 
the amount of cells injected is larger than the amount of cells injected in A and B; Pictures A and B were made at 
one day post injection. Pictures B and C were taken two days post injection. The images shown are examples 
taken by confocal microscopy of PaTu 8998t cells in which the cells were injected in the perivitelline space of 
zebrafish embryos. The induction of a new vessel induced by the tumour cells leads from the SIV to the PaTu 
8998t cell cluster. Two independent experiments are combined for each treatment and cell type and the 













Knock down of HOX genes influences tumour cell-induced angiogenesis 
 
To study tumour angiogenesis in vivo, a method is available that is based on the injection of pro- 
angiogenic mammalian tumour cells into the perivitelline space of zebrafish embryos (Nicoli, S., Presta 
M., 2007). PaTu 8988t and PaTu 8988s cells, AsPC-1 cells and Panc-1 cells were injected into the 
perivitelline space of zebrafish embryos at 48h post-fertilization. These pro-angiogenic tumour cell grafts 
induced an angiogenic response originating from the developing sub intestinal-vessels. In all four 
pancreatic cancer cell lines, the effects of control siRNA to gene specific siRNA for all 39 human HOX 
genes were compared. 
 
The results indicate that HOXA1, HOXA2, HOXA5, HOXB1, HOXB3, HOXB7, HOXB9, HOXB8 and 
HOXD10 knock downs resulted in inhibition of angiogenesis. However, knock downs of HOXA3, 






HOX genes regulate cell movement during gastrulation in the developing embryo. Mesoderm cells 
undergo an EMT as ingression (or involution) takes place. These processes are highly regulated and 
reflect collinearity: the 3’ to 5’ sequence of the Hox genes in a Hox cluster matches the sequence in 
which they act along body axes (HOX1 genes allow involution/ingression earliest). Each Hox gene has 
a space-time identity on the main body axis of the early embryo. The spatial position of expression 
and action of these genes is also determined by the developmental age at which they are expressed. 
This means that HOX1 genes are the first to be expressed and act at the cranial side of the embryo, 
whereas HOX10 genes determine the difference between thorax and abdomen on the body axis 
(HOX9 genes work a bit more anteriorly)(Durston AJ. et al., 2011; Durston AJ. et al., 2012). 
 
In the developing embryonic pancreas HOX1 genes, including HOXA1 and HOXD1 are expressed, 
together with genes from paralogue group 4 (HOXA4, HOXB4, HOXD4) (Slack JM., 1995). These genes 
seem not to be the most important genes whose signalling affects progression in pancreatic cancer. 
However, HOXA4 and HOXC4 induced metastasis and angiogenesis respectively (Miller GJ. et al., 
2003). 
 
HOX gene expression varies in different pancreatic cancer cell lines 
 
Expression of the human HOX complement was examined using PCR on tumour tissue. The results 
show that not all HOX genes are expressed and from the ones that are expressed, only a part exerts 
an effect in the performed assays. The last event could be due to redundancy between HOX genes 
(Meyers PZ., 2007). 
 
HOX genes of the paralogue groups 1 through 9 were previously shown to have the ability of blocking 
apoptosis (Morgan R. et al., 2014) and it was proposed that up-regulated expression of these genes 
resulted in a poor prognosis whereas gain of HOX genes of the paralogue groups 10-13 was 
suggested to result in a higher survival rate (Kachgal S et al., 2012). This is in accordance with our 
results regarding application of siRNAs against the paralogue group HOX10 and HOXC13 which 
induced malignant effects in the PaTu 8988s and AsPC-1 cell lines. 
 
Silencing of HOX genes results in altered migration 
 
Previously, the behaviour of PaTu 8988t cells in an in vitro migration assay was described (Marques I., 
 
2009; Vlecken DH. and Bagowski CP., 2009). The effects of the knock down of HOX genes in PaTu 
 




HOXB2 was shown to be expressed in non-resectable tumours and is associated with a poor 
prognosis (Alharbi RA., et al., 2013; Gray S. et al., 2011 ) and HOXB2 was previously shown to be 
involved in metastasis in lung cancer (Boimel PJ., et al., 2007). The data presented here shows that 
involvement of HOXB2 was merely evident in migration assays performed on PaTu 8988t cells (in 
vitro and in vivo). 
 
HOXB5 and HOXB6 were shown to be over expressed in pancreatic tumour tissue (Mizusawa N., et 
al., 2004) and HOXB6 was shown to be capable of induction of acute myeloid leukaemia as it is able 
to immortalizing cells (Magli MC., et al, 1997). Additionally, HOXB7 was previously shown to mediate 
EMT by inducing FGF (fibroblast growth factor) (Wu X., et al., 2006). Also, HOXB7 was shown to be 
over expressed in pancreatic cancer (AsPC-1 and Panc-1) (Gray S. et al., 2011) and was implicated in 
metastasis of lung cancer (Chen H., et al., 2008). Our results indicate that HOXB7 is only involved in 
angiogenesis in PaTu 8988t cells whereas none of the genes of the paralogue group 6 show any 
reactions to the siRNAs. However, another group of HOX genes was shown to be down-regulated in 
previous studies of which one is HOXD13, generally involved in development of the digestive and 
urogenital tract in embryos. HOXD13 (and also HOXB1 and HOXB3) were implied in suppression of 
metastasis (Gray S., et al., 2011) and therefore loss of HOXD13 is associated with a lower survival 
rate. Furthermore, it was shown that HOXB1 and HOXB3 are suppressed by miR-10a, which is present 
in significantly higher concentrations in metastatic pancreatic cancer (Marques I., et al., 2011). This 
finding confirms our data regarding these two genes on the non-metastable PaTu 8988s cells which 
disseminate in the absence of RNA of both genes. 
 
The results obtained with the in vivo assays differed to those obtained with the in vitro migration 
assay using PaTu 8990t cells (Figure 1). Metastatic behaviour in the zebrafish in vivo model (Figure 2) 
was abolished by an additional set of siRNA knock downs. As observed in an earlier study (Vlecken 
and Bagowski, 2009), the findings indicated significant qualitative and quantitative differences 
between the two assays and they demonstrate an important role for several additional HOX genes in 
metastatic behaviour of pancreatic cancer cells. The differences observed could be a result of 
embryonic factors that are not present in the media of cultured cells. 
 
HOX genes play a role in tumour induced angiogenesis 
 
Previous research showed that HOXA3 increases endothelial cell migration and induces angiogenesis 
in vivo (Mahdipour E., et al., 2011) instead of inhibiting the vessel formation. This is consistent with 
our results, because the effect that we observed by knocking HOXA3 out was inhibited vessel 
formation in PaTu 8988t cells. HOXB7 and HOXB9 were also indicated as involved in tumour 




similar to our results in PaTu 8988t cells where silencing of these genes inhibited vessel formation in 
the zebrafish embryos. 
 
The pancreas is located in the upper abdomen, near the junction with the thorax. HOX9 and HOX10 
are involved in defining this junction during embryonic development. Therefore it can be 
hypothesized that influence of these genes during carcinogenic processes in pancreatic cancer are 
location related rather than tumour type specific. Additionally, HOX9 and HOX10 genes are 
expressed at one of the later stages during embryonic development, due to the space-time identity 
of HOX genes on the body axes (Durston AJ. et al., 2011 and 2012) and this is in concordance with the 
age of the pancreatic cancer cells that were used for the experiments. 
 
The pancreatic cancer cells that were used form a representative selection; The PaTu 8988t and PaTu 
 
8988s cell lines used in this study originated from the same primary tumour (Elsässer HP., 1992). 
PaTu 8988t was observed to disseminate when transplanted into zebrafish embryos while PaTu 
8988s cells did not. Using these cell lines, both induction and reduction of malignant processes can 
be studied and compared. To expand the dataset, the AsPC-1 cell line and the Panc-1 cell line were 
added because they originate from different types of tumours of the human pancreas. Panc-1 
originates from an epithelioid tumour whereas AsPC-1 cells were derived from an adenocarcinoma 
(Chen WH., et al., 1982). 
 
Focussing on the effects that were similar for all cell lines, some pronounced features emerge. A 
number of HOX genes were not expressed according to PCR (Tables 1 and 2), while several other HOX 
genes are expressed but do not seem to have an effect in any of the assays described (Table 2). 
These were HOXA13, HOXB13, HOXC8, HOXC11, HOXC12, HOXD4 and HOXD13. Also, HOX genes from 
 
the paralogue group 6 (HOXA6, HOXB6, HOXC6) do not exert any effects in the assays performed in 
this study. Unfortunately, no consensus about oncogenecity or tumour suppressive properties was 
established in the literature. 
 
Whereas the oncogenic potential of certain HOX genes in human cancers has already been defined 
(Alharbi RA. et al., 2013; Magli MC. et al., 1997; Gray S et al., 2011; Shah N. and Sukumar S., 2010) , 
their role in neoplasms is still being evaluated. Progress has been hampered by the experimental 
approach used in many studies in which the expression of small subsets of HOX genes was analysed, 
and complicated by the functional redundancy implicit in the HOX gene system. Attempts to 
elucidate the function of HOX genes in malignant transformation will be enhanced by a better 
understanding of their upstream regulators and downstream target genes. Secondary tumours 
arising from cancer cell metastasis are the major cause of death in cancer patients, and currently no 




behaviour remain so far only partially understood and current models envision metastasis as a highly 
dynamic multi-step process. 
 
The zebrafish xenograft metastasis model used in this study provides the means to quantitatively 
study these dynamic processes in high-resolution in real time. Moreover, the zebrafish xenograft 
angiogenesis model allows further the investigation of tumour cell-induced angiogenesis in living 
embryos (Marques I., et al., 2009, Nicoli S., 2007 and 2008). It is important to note, that substantial 
evidence is accumulating that demonstrates functional conservation of human and zebrafish vascular 
biology and many pro-angiogenic genes have been described in both fish and men (Bussmann J., 
2008; Isogai S., 2003). Two zebrafish xenograft assays were used as powerful tools to address and 
compare the role of the 39 human HOX genes in metastatic behaviour and tumour cell-induced 
angiogenesis of human pancreatic cancer cells. The zebrafish xenograft metastasis and angiogenesis 
assays are well suited to help in delineating (e.g. by reverse genetics using siRNAs) the responsible 






Whereas the oncogenic potential of certain HOX genes in human cancers has already been reported, 
the role of these genes in neoplasms is still being evaluated. Progress has been hampered by the 
experimental approach used in many studies in which the expression of small subsets of HOX genes 
was analysed, and complicated by the functional redundancy in the HOX gene system. Attempts to 
elucidate the function of HOX genes in malignant transformation will be enhanced by a better 
understanding of their upstream regulators and downstream target genes. Secondary tumours 
arising from cancer cell metastasis are the major cause of death in cancer patients, and currently no 
anti-metastatic drugs are available for therapy. Moreover, the mechanisms that regulate metastatic 
behaviour remain so far only partially understood and current models envision metastasis as a highly 
dynamic multi-step process. We have shown that several HOX genes are implicated in the process of 
tumourigenesis in pancreatic cancer cells. Future work will be needed to elucidate the molecular and 
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Supplemental Table 1 
 





PaTu 8988t PaTu 8988s AsPC-1 Panc-1 
 A1 Expressed Expressed Expressed Expressed 
A2 Expressed Expressed Expressed Expressed 
A3 Expressed Expressed Expressed Expressed 
A4 Expressed Expressed Expressed No expression 
A5 Expressed Expressed Expressed Expressed 
A6 Expressed Expressed Expressed Expressed 
A7 Expressed Expressed Expressed Expressed 







A11 Expressed Expressed Expressed Expressed 
A13 Expressed Expressed Expressed Expressed 
B1 Expressed Expressed Expressed Expressed 
B2 Expressed Expressed Expressed Expressed 
B3 Expressed Expressed Expressed Expressed 
B4 Expressed Expressed Expressed Expressed 
B5 Expressed Expressed Expressed Expressed 
B6 Expressed Expressed Expressed Expressed 
B7 Expressed Expressed Expressed Expressed 
B8 Expressed Expressed Expressed Expressed 






C4 Expressed Expressed Expressed Expressed 
C5 Expressed Expressed No 
expression 
Expressed 
C6 Expressed Expressed Expressed Expressed 
C8 Expressed Expressed Expressed Expressed 
C9 Expressed Expressed Expressed Expressed 
C10 Expressed Expressed Expressed Expressed 
C11 Expressed Expressed Expressed Expressed 
C12 Expressed Expressed Expressed Expressed 
C13 Expressed Expressed Expressed Expressed 
























































Supplemental Table 2 
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HOX genes shown in italic were observed to cause an effect in the tested cells when knocked 



































Chapter 3: LIMK1 and LIMK2 are important for metastatic behaviour and tumour 
















The two LIM kinases, LIMK1 and LIMK2, are members of the PDZ/LIM family. These serine/threonine 
protein kinases are involved in actin cytoskeleton reorganization through phosphorylation and 
inactivation of ADF (actin depolymerizing factor)/cofilin. Different subcellular localizations of LIMK1 
and LIMK2 suggest different functions. Whereas LIMK1 is implicated in microtubule disassembly in 
endothelial- and cancer cells, activation of LIMK2 plays a role in cell cycle progression. To compare the 
role of the two LIM kinases in cancer related processes, we used a cell-based in vitro migration assay, 
as well as two zebrafish xenograft assays. We analyzed here the metastatic behaviour and tumour 
cell-induced neovascularization of pancreatic cancer cells in which both LIM Kinase genes were 
silenced by siRNAs. Both LIMK1 and LIMK2 single knock down led to a reduction of invasion and 
metastatic behaviour in the zebrafish xenograft metastasis assay. Interestingly, the double knock 
down completely blocked invasion and formation of micrometastasis in vivo. Moreover, in the 
zebrafish xenograft angiogenesis assay, we observed a reduction of pancreatic cancer cell-induced 
angiogenesis for both of the LIMK1 and the LIMK2 knock downs. Our results demonstrate similar 
functions for the two LIM kinases in pancreatic cancer cells and suggest an important role for both, 






Tumourigenesis involves interactions of cancer cells with each other, neighboring cells and their 
microenvironments, such as stromal cells or the blood vessels that supply oxygen and nutrients. 
Cancer cells often induce surrounding endothelial cells to build new vessels in order to balance this 
supply with the demand of a growing tumour. Blood vessels (as well as lymphatic vessels) are further 
used by metastasizing cancer cells for their long and short distance traveling. The complex 
mechanisms that regulate these “nomadic” cancer cells and governs the formation of metastases 
involves intravasation and extravasation in and out of blood- or lymphatic vessels. In order to 
successfully form a micrometastasis, cancer cells first need to take advantage of the vasculature 
and/or the lymphatics, and then after extravasation, have to settle and survive in an often hostile 
microenvironment. The importance to understand and prevent metastasis formation is underlined by 
the fact that over 90% of all cancer related deaths are due to secondary tumours arising from 
metastasizing cancer cells. 
 
The zebrafish has emerged as a novel in vivo cancer model to study both tumour-induced 
neovascularization (Nicoli, S., Presta M., 2007; Nicoli S., Ribatti D., 2007) and the formation of 
micrometastases of xeno-transplanted cancer cells (Haldi M., et al, 2006; Topczewska JM., et al,2006) 
and tumour fragments (Marques I., et al, 2009). In the transparent zebrafish embryos, invasion/ 
migration of tumour cells, their circulation in the vascular system, as well as the formation of 
micrometastasis and the tumour-induced neovascularization can all be followed with high resolution 
in real-time (Marques I., et al, 2009). Importantly, these zebrafish models allow to quantitate both 
metastatic behaviour of transplanted tumour cells and tumour-cell induced neovascularization 
(Nicoli, S., Presta M., 2007; Marques I., et al, 2009). In this study we use these models to characterize 
and compare the role of the two LIM Kinases in tumourigenesis of human pancreatic cancer cells. 
 
The LIM Kinases Leucine-rich immunoglobulin-like motif LIMK) are Serine/Threonine Kinases, which 
regulate actin polymerziation via phosphorylation and inactivation of ADF/cofilin (reviewed in (te 
Velthuis AJ., et al, 2007)). Actin dynamics contribute to cell motility, morphogenesis, division, 
differentiation, apoptosis and cancer. Given the importance of the cytoskeleton for most cellular 
functions, it is not surprising that the LIMKinases are ubiquitously expressed during development, and 
that disruption of normal LIMK expression and/or signaling is associated with numerous disorders. 
For example, abnormal expression of LIMK1 in humans has been associated with Williams syndrome 
(a severe mental disorder with profound deficits in visuospatial cognition) and Alzheimer’s disease 
(Heredia L., et al, 2006; Tassabehji M., et al, 1996). Two LIM Kinase genes are encoded in the human 




is located on chromosome 22 (22q12) (Mao X JT., et al, 1996; Okano I., et al,1995). Both genes 
 
encode for proteins with two N-terminal LIM domains, a C-terminal kinase domain and a PDZ domain 
in between. In addition to their role in regulating the actin cytoskeleton, LIMK1 has also been shown 
to play a role in microtubule disassembly (Gorovoy M., et al, 2005). 
 
In mice, ablation of LIMK1 leads to abnormalities in dendritic spine morphology and in synaptic 
function (Meng Y., et al, 2002). In contrast to Limk1 null mice, Limk2 knockout mice do not exhibit 
any impaired neuronal morphology or other phenotypic abnormalities in postnatal growth and 
development, except for impairment in spermatogenesis (Takahashi H., et al, 2002). However, when 
a double knockout was applied, the neuronal phenotype appeared more pronounced than in the 
genetic deletion of Limk1 alone (Meng Y., et al, 2004). For both LIM Kinases, cell type specific 
functions have been suggested and their cellular localization was found to differ in vertebrates 
(Acevedo K., et al, 2006; Ott EB., et al,2007). While LIMK1 is found in focal adhesions, LIMK2 is shown 
 
to be localized in endosome-like punctae (Acevedo K., et al, 2006). Recently, it was demonstrated 
that activation of LIMK2, but not LIMK1, by ROCK (Rho-associated, coiled-coil containing protein 
kinase) in 3T3 cells led to increased levels of cyclin A and cell cycle progression (Croft DR., Olson MF., 
2006). Increased cell cycle progression was also evident in MDA-MB-435 cancer cells overexpressing 
LIMK1 (Rozita Bagheri-Yarmand AMAASRK, 2006). Thus both LIM Kinases have been shown to play a 
role in cell cycle progression, but in a cell-type specific manner (Sumi T., et al, 2002). 
 
To date, robust evidence suggests that LIMK1 activity is important for cancer cell metastasis. High 
expression levels of LIMK1 are observed in invasive breast and prostate cancer cell lines and in 
malignant human prostate tumours (Wang W., et al, 2006). Overexpression of LIMK1 increases the 
invasiveness of non-invasive breast and prostate cancer cells in vivo and in vitro; while expression of 
dominant-negative kinase-dead LIMK1 or LIMK1 anti-sense RNA greatly reduced the invasiveness of 
breast and prostate cancer cells, respectively (Wang W., et al, 2006). The mechanism by which LIMK1 
increases the invasiveness of cancer cells is not yet clear. It may be due to increased cell cycle 
progression, increased motility and also as recently suggested to increased expression levels of the 
serine protease urokinase type plasminogen activator (uPA) and its receptor, known to be involved in 
metastasis (Rozita Bagheri-Yarmand AMAASRK, 2006). These latter findings suggest an important role 
for LIMK1 signaling in breast cancer tumour growth, angiogenesis and invasion and a regulatory 
connection between LIMK1 and the uPA system (Rozita Bagheri-Yarmand AMAASRK, 2006). Whether 
all these mechanisms are important in tumour progression or if only a few play a part, is not known 
and needs to be determined in the future. Notably, in contrast to LIMK1, the role of LIMK2 in tumour 




In this study, we have investigated the function of LIMK1 in metastatic behaviour of pancreatic 
cancer cells and compared it to the role of LIMK2. We further tested the hypothesis that both LIM 




Materials and Methods 
 
Animal care and handling 
 
Tg(fli1:eGFP) zebrafish were kept at 28°C in aquaria with day/night light cycles (10h dark versus 14h 
light periods). The developing embryos were kept in an incubator at constant temperatures (which 
were varied according to the experimental requirements).The zebrafish were handled in compliance 




The two human pancreatic cancer cell lines, PaTu 8988t (Elsässer HP LU., et al, 1992) were cultured in 
DMEM high glucose, with 10% FCS and 1:100 Pen/Strep and Panc-1 (Lieber M MJ., et al, 1975) were 
cultured in RPMI with 15% FCS and 1:100 Pen/Strep. PaTu 8988t were derived from a liver metastasis 
over a decade ago (Elsässer HP LU., et al, 1992) and we had earlier described the cell line in detail 
and its behaviour in an in vitro wound healing assay and in the zebrafish xenotransplantation assay 
 
(Marques I., et al, 2009). 
 
siRNA treatment of pancreatic cancer cells and control PCR 
 
The siRNAs for silencing human LIMK1 and human LIMK2 were purchased from Santa Cruz 
Biotechnology (LIMK-1: sc-35810 and LIMK-2: sc-35812). The EndoPorter system (Gene Tools, LLC) 
was used to deliver siRNAs into pancreatic cancer cells. To test for unspecific effects, a control siRNA 
(Control siRNA-A sc-37007; Santa Cruz Biotechnology) was used, which contains a scrambled 
sequence that will not lead to the specific degradation of any known cellular mRNA. All siRNAs were 
used at a final concentration of 50 nM. The efficiencies of LIMK-1 and LIMK-2 siRNAs were tested by 
an RT-PCR, which we described previously including total RNA preparation (van der Meer DLM, et al, 
2006). The annealing temperature was set to 55° C and the extension temperature to 72° C. For the 
amplification, the commercially available primer pairs of human LIMK1 and LIMK2 were used (LIMK1 
primer pair: sc-35810-PR fragment size = 419 bp and LIMK-2 primer pair: sc-35812 fragment size = 
594 bp; both Santa Cruz Biotechnology). 
 
Cell staining, transplantation and incubations 
 
Cells were stained with CM-Dil (red fluorescence) (Vybrant, Invitrogen). Cells were seeded in 6-well 
plates, grown to confluency and then trypsinized. Subsequently, cells were washed with 67% DPBS 
(GIBCO, Invitrogen), transferred to 1.5 ml Eppendorf tubes and centrifuged 5min, at 1500rpm. Cells 
were re-suspended in DPBS (Dulbecco’s phosphate buffered saline) containing CM-Dil (4ng/ul 




Subsequently, cells were centrifuged 5 min at 1500 rpm, the supernatant discarded and cells re- 
suspended in 100% FCS, centrifuged again and washed 2 times with 67% DPBS. Cells were now 
suspended in 67% DPBS for injection into the embryos. 2 dpf zebrafish embryos were dechorionated 
and subsequently anesthetized with tricaine (Sigma). Using a manual injector (Eppendorf; Injectman 
NI2), the cell suspension was loaded into an injection needle (15 μm internal- and 18 μm external 
diameter) and cells were injected in Tg(fli1:eGFP) zebrafish embryos. After injection, embryos were 
incubated for 1h at 31oC and checked for cell presence at 2 hours post transplantation (hpt). Fish 
with fluorescent cells outside the implantation area at 2 hpt were excluded from further analysis. All 
other fish were incubated at 35oC for the following days. 
 
In vitro migration assay (“scratch”-assay) 
 
The in vitro migration assay was carried out as previously described (Liang C-C., et al, 2007). Cells 
were grown to confluency in 6-well dishes. Then the cell monolayer was scraped in a straight line 
with a 200 μl pipette tip. Pictures of the scratch were taken under a Leica stereomicroscope at 0h, 
24h and 48h and the gap was measured and gap closure was calculated in percentage to the initial 
gap (scratch). 
 
Zebrafish xenograft angiogenesis model (Tumour-cell induced neovascularization assay) 
 
The tumour-cell induced neovascularization assay was in general performed as previously described 
(Nicoli, S., Presta M., 2007; Nicoli S., Ribatti D., 2007). In detail, 48 hpf zebrafish embryos were 
dechorionated and anesthesized using 0.042 mg/ mL Trincaine (Sigma, St. Luis, MO) and put on a 1,8 
% Agarose dish for injections. Cells were prepared as described above, then suspended in 20 µl 12,0 
mg / ml Matrigel solution (Cultrex R Basement Membrane Extract, R&D systems, Minneapolis, USA) 
and kept on ice for a short period until injection. The CellTram Oil injector (Eppendorf, Hamburg, 
Germany) was loaded by using a manual injector (Eppendorf; Injectman NI2). An aliquot of 5 µl of the 
cell suspension in Matrigel was loaded into an injection needle, and embryos were injected as 
described in more detail in previous studies (Nicoli, S., Presta M., 2007; Nicoli S., Ribatti D., 2007). 
After injection, embryos were incubated at 35°C for 24 h. Embryos were checked and photographed 




Confocal pictures were taken with the Biorad Confocal microscope 1024ES (Zeiss microscope) 
combined with a Krypton/Argon laser. For light-microscopy images of pancreatic cells, a Leica 






LIMK1 and LIMK2 are important for migration of human pancreatic cancer cells in vitro 
 
Despite their well-documented role in regulation of actin polymerization and microtubule disassembly 
(Bernard O., 2007), studies comparing other biological functions of LIMK1 and LIMK2 are limited. In 
contrast to the well described role of LIMK1 in cell migration/invasion e.g. of breast cancer cells (Ding 











Figure 1: Semi-quantitative RT-PCR and in vitro migration assay of pancreatic cancer cell lines. (A) Semi 
quantitative RT-PCR shows that LIMK1 and LIMK2 are expressed in PaTu 8988t and in Panc-1 cells and gene 
specific siRNAs for LIMK1 and LIMK2 silence the respective genes by abolishing mRNA expression. Control GAPDH 
expression was analyzed by RT-PCR of the same RNA samples. This loading control is shown in the lower panel. 




in the middle panel. (B) An in vitro migration assay ('scratch assay') shows differences in migration of PaTu 8988t 
cells treated with control siRNA (Control), LIMK1 siRNA , LIMK2 siRNA or LIMK1 plus LIMK2 siRNA (LIMK1 and 2). 
Gap closure (gap width) over time is shown in percentages compared to the 0h time point (set to 100%). Similar 
results were obtained in three independent experiments and error bars show Standard Deviations between the 
three experiments. On average on day 1 (24 h) for LIMK1 16.4%, LIMK2 
10.3%, LIMK1/2 18% and the control 51.8% of the gap was closed. On day 2 (48 h) for LIMK1 53.6%, LIMK2 
 
10.3%, LIMK1/2 18% and the control 51.8% of the gap was found closed. Similar results were obtained in three 
independent experiments. 
 
Both LIM Kinases had been shown to be expressed in the human pancreas, with LIMK2 showing a 
relatively high abundance compared to several other tissues (Smolich B., et al, 1997). We found that 
LIMK1 and LIMK2 are both expressed in the pancreatic cancer cell line, PaTu 8988t (Figure 1A). 
 
In this study, we were interested in the diverse and common functions of LIMK1 and LIMK2 in cancer 
related processes. In an in vitro migration assay (also called in vitro scratch assay) (Liang C-C., et al, 
2007), we investigated the effects of LIMK1 and LIMK2 knock down in two pancreatic cancer cell 
lines, PaTu 8988t and Panc-1 cells. We had previously described the behaviour of PaTu 8988t cells in 
an in vitro migration assay (Marques I., et al, 2009). We used gene specific siRNAs to silence the 
LIMK1 and LIMK2 genes in this cell line and in addition to the respective single knock downs, we 
performed a LIMK1/2 double knock down. Confirmation of gene silencing in PaTu 8988t cells was 
obtained by semi-quantitative RT-PCR (Figure1A). The results of the in vitro migration assay using 
PaTu 8988t and Panc-1 cells showed that both, LIMK1 and LIMK2 knock down have an inhibitory 
effect on gap closure over time (Figure 1B and C). The double knock down had no additive effect and 
inhibition was comparable to that exerted by both single knock downs (Figure 1B and C). These 
findings suggest a role for both LIM kinases in invasion/migration of pancreatic cancer cells. 
 
LIMK1 and LIMK2 both play a role in metastatic behaviour of human pancreatic cancer cells 
 
In a previous study we have demonstrated that fluorescently labelled PaTu 8988t cells and tumour 
fragments allow for in vivo imaging of metastatic behaviour (Marques I., et al, 2009). PaTu 8988t cells 
rapidly invaded the zebrafish body, translocated into the vasculature and colonized at distant sites in 
the zebrafish larvae (5 days post fertilization (dpf)) forming micro-metastases (Marques I., et al, 
2009). The sensitivity of the zebrafish tumour xenograft metastasis model allows observation of 
individual cells and their daughter cells in vivo and thereby enables the quantification of metastatic 
behaviour in vivo. To study the role of the LIM Kinases in metastatic behaviour, we labelled two 
pancreatic tumour cell lines with a carbocyanine dye (CM-Dil) and ectopically transplanted them in 




transgenic  zebrafish line,Tg(flil:eGFP) (Lawson ND.,et al, 2002), which expresses GFP under the flil 
promotor (an early endothelial marker)  and therefore exhibits  a green fluorescent vasculature 


















(A) Shown are example pictures taken by confocal microscopy of xeno-transplanted PaTu 8988t cells either 
treated with the control siRNA (a and b) or the LIMK1/2 siRNAs (d and e). The pictures show the zebrafish 
directly after transplantation (2 dpf) and 24 hours later (3dpf). In the control, cancer cells have invaded the 
embryo and migrated to distant sites (b). This behaviour is blocked by the double knock down (e). The area 
marked with a square (b) is shown in an enlargement (c) and here, cancer cells are visible in the vasculature (c). 
(B) Shown are results of the Zebrafish tumour xenograft metastasis assay performed in two different pancreatic 
cancer cell lines. Two independent experiments are combined for each treatment and cell type. The standard 
deviations (SD) are shown in brackets. The results are also represented in the graph in Figure 2 and all 







We used once again gene specific siRNAs to silence the LIMK1 and LIMK2 genes individually as well as 
in combination in the LIMK1/2 double knock down and investigated the effects in the zebrafish 
xenotransplantation model. Our results, obtained in two different pancreatic cancer cell lines, 
showed that both LIMK1 and LIMK2 knock down lead to inhibition of metastatic behaviour (Figure 2). 
These results were not identical but similar to the effects we observed in the in vitro migration assay 
using PaTu 8988t cells (Figure 1B and C). However, in contrast to the in vitro migration assay where 
the double knock down had no additional inhibitory effect, it completely abolished metastatic 
behaviour in the zebrafish in vivo model (Figure 2 A and B). This was observed for both pancreatic 
cancer cell lines investigated. These findings indicate significant qualitative and quantitative 
differences between the two assays and they demonstrate an important role for both LIM Kinases in 
metastatic behaviour of pancreatic cancer cells. 
 
Knock down of LIMK1 and LIMK2 inhibits tumour cell-induced neovascularization 
 
Tumour-induced angiogenesis and the recruitment of new blood vessels by solid tumours is an 
essential component of the process leading to the formation of metastasis. The tumour-induced 
newly built vessels provide the principal route by which tumour cells exit the primary tumour site 
and enter the circulation. Recently, it had been shown that human MDA-MB-435 cancer cells xeno- 
transplanted into athymic nude mice showed not only increased tumour growth but also promoted 
tumour angiogenesis, when they overexpressed LIMK1 (Rozita Bagheri-Yarmand AMAASRK, 2006). 
For LIMK2 similar effects had not been described. 
 
Recently, a method has been established to study tumour angiogenesis in zebrafish (Danio rerio) 
 




zebrafish embryos (Nicoli, S., Presta M., 2007; Nicoli S., Ribatti D., 2007). This zebrafish tumour 
xenograft angiogenesis assay allows observation of tumour cell-induced angiogenesis in real time. 
 
Here we describe how we used this method to study the role of the two LIM Kinases in tumour cell- 
induced angiogenesis. We injected two pro-angiogenic human pancreatic cancer cell lines, PaTu 
8988t (PaTu 8988t) (Elsässer HP LU., et al, 1992) and Panc-1 (Lieber M MJ., et al, 1975), into the 
 
perivitelline space of zebrafish embryos at 48h post-fertilization. These pro-angiogenic tumour cell 
grafts induce a neovascular response originating from the developing subintestinal vessels. In both 
pancreatic cancer cell lines, we compared the effects of control siRNA treatment to LIMK1 and LIMK2 
gene specific siRNA treatment. We also performed a LIMK1/2 double knock down. Successful gene 
silencing was controlled by RT-PCR in PaTu 8988t cells (Figure1 A). Our results revealed that both 
LIMK1 and LIMK2 knock down inhibit tumour cell-induced angiogenesis (Figure 3). The double knock 
down displayed a slightly additive inhibitory effect but did not lead to complete inhibition of tumour- 
induced angiogenesis (Figure 3). To the best of our knowledge, this is the first indication that LIMK2 





Figure 3: The zebrafish tumour xenograft angiogenesis assay. (A) Images shown are examples taken by confocal 
microscopy of PaTu 8988t cells 24 hours after cells were injected in the perivitelline space of zebrafish 
embryos. PaTu 8988t cells were either treated before implantation with the control siRNA (left image) or the 
 
LIMK1/2 siRNAs (right image). The picture on the left shows the induction of a new vessel induced by the 
tumour cells leading from the SIV to the PaTu 8988t cell cluster. This is inhibited by the double knock down 
shown in the right image. (B) Shown are the results of the Zebrafish tumour xenograft angiogenesis assay 
performed in two different pancreatic cancer cell lines. Two independent experiments are combined for each 
treatment and cell type and the number of zebrafish used for each individual treatment was 50. Standard 
deviations (SD) are shown in brackets and the results are also represented in Supplemental Table 1 (Vlecken 






Secondary tumours arising from cancer cell metastasis are the major cause of death in cancer 
patients, and currently no anti-metastatic drugs are available for therapy. Moreover, the mechanisms 
that regulate metastatic behaviour remain so far only partially understood. The current models 
envision metastasis as a highly dynamic multi-step process. 
 
The zebrafish xenograft metastasis model used in this study provides the means to quantitatively 
study these dynamic processes in high-resolution in real time. Moreover, the zebrafish xenograft 
angiogenesis model allows further the investigation of tumour cell-induced neovascularization in 
living embryos. It is important to note, that substantial evidence is accumulating that demonstrates 
functional conservation of human and zebrafish vascular biology and many pro-angiogenic genes 
have been described in both fish and men (Bussmann J., et al, 2008; Isogai S., et al, 2003). 
 
We used the two zebrafish xenograft assays here as powerful tools to address and compare the role 
of the LIM Kinases in metastasis and tumour cell-induced angiogenesis of human pancreatic cancer 
cells. We discovered here that LIMK1, which has been implicated in tumour cell metastasis in various 
tumour types, is also important for the metastatic behaviour of pancreatic cancer cells. More 
importantly, our data gives the first evidence that LIMK2 can play a similar role in metastasis 
formation. Non-overlapping functions of these two kinases in pancreatic cancer cells are 
demonstrated by the complete abolishment of metastatic behaviour by the double knock down. 
Interestingly, this differs from our in vitro data, where a double knock down had no additional 
inhibitory effect. A possible explanation is that the results in the in vitro migration assay reflect the 
contribution of the LIM Kinases to the initial step of invasion/migration and in part to cell 
proliferation, which are both measured in this assay. Cell proliferation, which has been shown to be 
regulated by both LIM Kinases (Croft DR., Olson MF., 2006; Rozita Bagheri-Yarmand AMAASRK, 
2006), certainly plays a partial role in the gap closure times which were measured in the in vitro 
migration assay. Overall, the results point to additional roles (despite regulation of 
invasion/migration) of the LIM Kinases in later steps of metastasis formation. Similar non-overlapping 
functions for LIM Kinases have also been implicated in knock-out mice, where double ablation of 
LIMK1/2 induced a more pronounced neuronal phenotype than in the genetic deletion of Limk1 
alone (Meng Y., et al., 2004). Although LIMK2 ablation alone did not lead to any impaired neuronal 
morphology, these results revealed redundancies between the two LIM Kinases (Takahashi H., et al, 
2002). 
 
Although LIMK1 had been implicated in angiogenesis induced by xeno-transplanted human MDA-MB- 
 




attributed to LIMK2. In our zebrafish xenograft angiogenesis study, we observed a reduction of 
pancreatic cancer cell-induced angiogenesis for both, the LIMK1 and the LIMK2 single knock downs. 
However, the double knock down did not exert a complete inhibition and only had a slightly more 
pronounced inhibitory effect compared to the single knock downs. 
 
The mechanisms by which LIM Kinases increase the invasiveness of cancer cells and their metastatic 
behaviour and tumour-induced angiogenesis have not been identified yet. The zebrafish xenograft 
metastasis and angiogenesis assays are well suited to help in delineating (e.g. by reverse genetics 
using siRNAs) the responsible mechanisms and will assist in discovering novel anti-metastatic drugs in 
the not so distant future. 
 
In summary, we find here that in addition to LIMK1, LIMK2 is also very important for metastasis of 
pancreatic cancer cells. A LIMK1/2 double knock down is necessary to completely block metastatic 
behaviour in vivo. We further show that both LIM Kinases play an important role in tumour cell- 
induced angiogenesis. Our findings propose that simultaneous targeting of both LIM Kinases might 
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Substitutionally inert metal complexes are promising emerging scaffolds for targeting enzyme active 
sites. (Meggers E., 2007) Our group has demonstrated over the last several years that inert 
ruthenium (II) complexes can serve as highly selective nanomolar and even picomolar inhibitors of 
protein kinases. (Meggers E., et al., 2007) Octahedral metal coordination geometries in particular 
offer new gateways to design rigid, globular molecules with defined shapes that can fill protein 
pockets such as enzyme active sites in a unique fashion (Figure 1) (Maksimoska J., et al., 2008). 
However, the large number of possible stereoisomers does not only provide new structural 
opportunities (e.g. the complex illustrated in Figure 1 can form up to 24 stereoisomers if the ligands 
A-D differ), but also poses a formidable challenge due to the limited ability to control 
stereochemistry in the course of ligand exchange reactions (Coe B. J. and Glenwright, S. J., 2000). A 
continued progress in this area of inorganic medicinal chemistry therefore requires the development 
 
of strategies for the stereo-controlled synthesis of octahedral metal complexes. Although most of our 
previous efforts were focused on ruthenium (II) complexes, we envisioned that octahedral iridium(III) 
(Ir(III)) complexes might be attractive scaffolds for two reasons: First, coordinative bonds with Ir(III) 
tend to be very inert (J. Burgess, 1972) and therefore Ir(III) complexes should be able to serve as stable 
scaffolds for the design of enzyme inhibitors (Kwon T.H. et al., 2008; Yu M. et al., 2008; K. K. 
W. Lo et al., 2008). Second, octahedral Ir(III) complexes can be accessed from square planar Ir(I) 
 
complexes by stereospecific oxidative addition reactions (Mondal J. U. and Blake D. M., 1982. This 
provides a powerful tool to control the stereochemistry of octahedral Ir(III) complexes. In this study, 
we present the discovery of a bioactive octahedral iridium (III) complex, synthesized through 
oxidative addition as the key synthetic step. The organometallic compound functions as a nanomolar 
and selective inhibitor of the protein kinase Flt4 (Fms-related tyrosine kinase 4), also known as 
VEGFR3 (vascular endothelial growth factor receptor 3) (Karkkainen M. J. and Petrova T., 2000). Flt4 is 
involved in angiogenesis and lymphangiogenesis (Karkkainen M. J. and Petrova T., 2000) and we 
demonstrate that this nontoxic organoiridium compound can indeed interfere with the development 










































Figure 1. Illustration of an octahedral pyridocarbazole metal complex bound to the active site of a protein 








We started with iridium complexes containing our recently developed pyridocarbazole 
pharmacophore bidentate ligand that targets the compounds to the ATP-binding site of protein 
kinases (Figure 1). For initial synthetic studies we used the benzyl protected ligand 1a and reacted it 
with [IrCl(COD)]2 (COD = 1,5cyclooctadiene) in MeCN/MeOH (2:1) in the presence of K2CO3 to afford 
the iridium (I) complex 2a in 94% (Scheme 1). This slightly air sensitive complex efficiently undergoes 
oxidative addition. For example, the reaction of 2a with freshly distilled CH3I in the dark provided the 
stable octahedral complex 3a (89%) stereospecifically as the trans oxidative addition product (G. 
Mestroni, 1974). Similarly, the reaction of 2a with I2 afforded the octahedral complex 4a in 88%. A 




Importantly, the iodide ligands in 4a can further be subjected to substitution chemistry, as 
exemplified by the conversion to the dichloride complex 6 upon treatment with 
tetrabutylammonium chloride (TBAC) (88%). 
 
Encouraged by these results, we synthesized in an analogous fashion, starting with the TBS (Tris 
buffered saline)-protected pyridocarbazole 1b, a small library of iridium complexes 7-11 bearing 
unprotected maleimide moieties essential for undergoing hydrogen bonds with the hinge region of 









Scheme 1.Synthesis of octahedral iridium complexes through oxidative addition as the key step. 
Reaction conditions a-c: a) TBAC, THF, 79% of 8; b) KSeCN, DMF, 83% of 9; c) MeMgBr, CuI, THF, 63%; 
TBAF, CH2Cl2, 73% of 10; d) TBAC, THF, 88% of 6, 59% of 7, and 71% of 12; e) TBAC, THF, microwave 



































Figure 2. ORTEP representation (50% thermal ellipsoids) of the crystal structure of complex 4a. Selected bond 
distances: N1-Ir1. 2.070(6), N4-Ir1 2.122(6), C28-Ir1 2.240(8), C29-Ir1 2.251(7), C32-Ir1 2.222(7), C33-Ir1 
2.252(7), I1-Ir1 2.733(6), I2-Ir1. 2.714(6) Å. Selected bond angles: N1-Ir1-I2 82.29(16), N4-Ir1-I2 81.44(16), N1- 







In order to quickly evaluate the kinase inhibition properties of this class of iridium complexes, we 
selected compound 8 as a representative member and screened it against a panel of protein kinases. 
As a result, at a concentration of 1 μM 8 and 10 μM ATP only 12 out of 263 kinases showed activities 
below 25% (see supporting information). Intriguingly, the receptor tyrosine kinase Flt4 (Fms-related 
tyrosine kinase 4), which was not selectively inhibited by any of the previously reported ruthenium 
scaffolds, (Meggers E., 2007; Meggers E., et al., 2007) displayed under these conditions only an 




compounds 7-11 against this kinase by determining the concentrations of 7-11 at which Flt4 kinase 
activity was reduced to 50% (IC50) at an ATP concentration of 100 μM. As expected, ligands X and Y of 
compounds 7-11 (Scheme 1) turned out to have a profound effect on the inhibition properties. 
Whereas compound 8 displayed an IC50 value of 211±23 nM, the more hydrophobic dimethyl 
derivative 10 had a significantly lower potency (IC50 = 1007±129 nM). Replacing the CH3 group in 8 
against CF3 also reduced affinity with an IC50 value of 369±68 nM for 11. Furthermore, as seen for 
compound 9, substituting the chloride for selenocyanate decreased the inhibition potency slightly 
compared to complex 8 (IC50 = 326±52 nM for complex 9). However, complex 7 with X = Y = Cl 
showed a significantly improved activity with an IC50 value of 123±14 nM, thus being almost an order 
 
of magnitude more potent against Flt4 than the related dimethyl derivative 10. From these data it 
becomes apparent that the ligands X and Y have a profound effect on the kinase inhibition properties 
in this class of compounds and the small library of organoiridium complexes 7-11 already spans 
across an activity range of almost one order of magnitudes. This observation is consistent with 
previous studies of organometallic protein kinase inhibitors which revealed the importance of the 
ligands oriented perpendicular to the pyridocarbazole moiety (ligands A and C in Figure 1) for kinase 
binding, especially the ligand pointing towards the glycine-rich-loop (ligand A in Figure 1) (Bregman 
H., 2006). Our results thus demonstrate that oxidative addition provides a convenient synthetic tool 
to quickly scan ligands in the positions perpendicular to the pyridocarbazole moiety, which to our 
opinion is a unique feature of this iridium scaffold. 
 
For the purpose of designing compounds as molecular probes for chemical biology, the selectivity of 
 
a compound is one of its most important single features. This is especially a challenge for members of 
large enzyme families such as protein kinases with more than 500 putative protein kinase genes 
encoded in the human genome. Nevertheless, iridium complex 7 displays a remarkable degree of 
selectivity for Flt4 over other protein kinases. Figure 3 shows the results of a screening of complex 7 
against a panel of 229 human wild type protein kinases at a concentration of 100 nM (10 μM ATP). 
Out of the 229 protein kinases, 224 kinases remained an activity of more than 50%, including other 
members of the VEGFR family such as VEGFR1 (also known as Flt1, 62% activity at 100 nM 7, 10 µM 
ATP) and VEGFR2 (also known as KDR, 95% activity at 100 nM 7, 10 µM ATP). On the other hand, only 
5 kinases, including Flt4, were inhibited by more than 50% under these conditions. IC50 
 
measurements with some of these kinases at the biologically more relevant concentration of 250 μM 
ATP confirmed the exquisite selectivity of 7 for Flt4: Pim1 (IC50 = 560±8 nM) and GSK3 (measure for 
the more potent α-isoform: IC50 = 338±42 nM) are inhibited with potencies which are lower compared 




that the high selectivity of the organometallic complex 7 renders it a promising tool for investigating 
 






































































Remaining Activity with 100 nM7 
 
Figure 3. Selectivity profile of iridium compound 7 in a panel of 229 human wild type protein kinases. 
Determined by Millipore (KinaseProfiler) at a concentration of 10 μM ATP. Remaining activities are mean values 
from duplicate measurements. Selectivity comparison within the VEGFR family (remaining activities at 100 nM 
7): Flt1 (VEGFR1) = 62%, KDR (VEGFR2) = 95%, Flt4 (VEGFR3) = 32%. Protein kinases which were inhibited by 




The receptor tyrosine kinase Flt4 plays essential roles in the development and maintenance of 
lymphatic vessels as well as in the development of the embryonic cardiovascular system (Karkkainen 
M. J. and Petrova T., 2000). In early mouse embryos it has been shown that a targeted inactivation of 
the Flt4 gene results in defective blood vessel formation (Dumont D.J., 1998). Similarly, it has been 
demonstrated that Flt4 signalling is required for vasculogenesis and angiogenesis in the developing 
zebrafish (Ober E. A. et al., 2004). We therefore tested the effect of complex 7 on angiogenesis and 
tumour-induced neovascularization in two zebrafish models (Bergamo A. et al., 2002; Ott I. et al., 




system exhibits green fluorescence due to the expression of the green fluorescent protein (GFP) under 
an early endothelial promoter, were exposed to the organometallic compound 7. The subsequent 
analysis with confocal fluorescence microscopy demonstrated that compound 7 induces a significant 
damage to the vessel formation with 79% and 100% of the zebrafish embryos being affected 3 days 
post fertilization at concentrations of 1 µM and 5 µM, respectively (Table 1). Figure 4 gives an example 








Figure 4. Effect of iridium compound 7 on angiogenesis and tumourcell-induced neovascularization in 
transgenic zebrafish embryos exhibiting a green fluorescent vascular system. a, b) Angiogenesis assay: 
Examples of laser scanning confocal microscopy images shown at 3 days post fertilization of zebrafish 
embryos treated with DMSO (a) or compound 7 at 5 µM (b). Vessel defects are marked with white 
arrows. c,d) Tumour xenotransplantation angiogenesis assay: Embryos were transplanted with human 
pancreatic cancer cells (red fluorescent due to CM-Dil staining) and treated with DMSO control (c) or 
compound 7 at 5 µM and images taken by dual laser scanning confocal microscopy at 24 hours post 
transplantation. The outgrowth of the subintestinal vein (SIV) in the control experiment is marked 













Inhibition of angiogenesis 
 



































[a] See Supporting information for experimental details. [b] Given are the percentages of 
embryos with defects in dorsal longitudinal anastomic vessels (DLAV), intersegmental vessels 
(IV) or/and subintestinal veins (SIV) formation after 72 hours post fertilization. Percentages 
of surviving embryos under the experimental conditions are also indicated. Three 
independent experıments were peformed with 100 embryos each. No phenotypic differences 
were observed for the solvent control and the Nmethylated compound compared to 
untreated embryos. [c] Given are the percentages of embryos with induced vessel formation 
at 24 hours post injection of tumour cells. Two independent experiments were performed 
and 80 embryos were investigated for each concentration and compound. Non-transplanted 
zebrafish embryos do not show a similar formation of 







  Discussion and conclusion 
New blood vessel development is an important process in tumour progression (Kerbel R. S., 2008). 
Next, in order to evaluate the inhibitory effect of compound 7 on tumour-cell-induced angiogenesis, 
 
we used an in vivo tumour xenograft angiogenesis assay in zebrafish embryos (Nicoli, S. and Presta, 
M., 2007; Nicoli S. et al., 2007). This neovascularization assay allows to follow the induction of blood 
vessel formation by xeno-transplanted pro-angiogenic human cancer cells, in this study transplanted 
human pancreatic tumour cells (PaTu 8998T cells), in real-time in living zebrafish and enables the 
quantification of neovascularization in vivo and in high resolution. Revealingly, our results show 
inhibitory effects of 7 on tumour-cell-induced angiogenesis. For example, compound 7, when added 
to the water containing the zebrafish embryos at two nonlethal concentrations, strongly inhibited the 
induction of new microvasculature in the zebrafish neovascularization assay (Table 1). Figure 4 
visualizes the effect of compound 7: Whereas zebrafish embryos treated with DMSO show the typical 
tumour-cellinduced outgrowth of the subintestinal vein (marked with two arrows in Figure 4c), the 
formation of new blood vessels is suppressed successfully in the presence of 5 µM of iridium 
compound 7 (Figure 4d). 
 
Taken together, these data show that compound 7 has antiangiogenic properties in vivo and inhibits 
both, angiogenesis in developing zebrafish embryos as well as tumour cell induced angiogenesis. 
Importantly, the related organometallic complex 12 (Scheme 1), having an identical coordination 
sphere around the iridium(III) center but lacking the ability to inhibit protein kinases effectively due 
to a methylated maleimide moiety (Flt4: IC50 = 1520 nM at 100 µM ATP), does not show any effects 
at similar concentrations in these two zebrafish assays (Table 1). This pronounced difference in 
bioactivities between the organometallics 7 and 12 strongly suggests that it is the inhibition of 
protein kinases, most likely Flt4, which is responsible for the in vivo bioactivity of the organometallic 
compound 7. 
 
Organometallic compounds are traditionally disregarded as molecular scaffolds for the design of 
drug-like molecules or molecular probes due to the fear of toxicity resulting from an incompatibility 
of metal-carbon bonds with the biological environment. However, as shown in Table 1, the 
organoiridium Flt4 inhibitor 7, containing multiple Ir-C bonds, does not affect the survival of the 
zebrafish embryos. Furthermore, cellular proliferation experiments with Hela cells confirm the low 
cytotoxicity of 7 with Hela cells being not affected significantly in the presence of 1 µM 7 over 24 
hours (see Supplementary Information). 
 
In conclusion, we herein report the first example of a protein kinase inhibitor based on an octahedral 




addition. The high in vitro selectivity, presumable due to the overall scaffold rigidity, combined with a lacking 
cytotoxicity and the distinct in vivo biological activity in two zebrafish model systems 
indicates that organoiridium complexes such as 7, containing an octahedral metal center and 
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Currently, biological and organic substances are globally screened for development of a new 
generation of therapeutics active against cancer. Amongst the snake venoms, candidates have been 
identified which exhibit promising properties. In this pilot study, snake venoms from different species 
(Naja anulifera, Naja kaouthia, Ophiophagus hannah and Echis carinatus ) were investigated for their 
anti-malignant properties on pancreatic cancer cells. To this end, cells were incubated with different 
venoms and subsequently subjected to in vitro cell death and migration assays and in vivo 
dissemination and angiogenesis assays. For the in vivo assays, the cells after incubation and labelling 
were subjected to transplantation into the yolk sac of zebrafish embryos and monitored for motility 
and angiogenesis. Since there were few effects observed in the vivo assay, we soaked fish injected 
with untreated cells in the different venom solutions. The results showed that strong effects occur in 
in vitro samples treated with venoms derived from Ophiophagus hannah and Echis carinatus. 
Conversely, in the in vivo assays, venom derived from N. naja had the most beneficiary effects with 






At present, biological and organic compounds are promising candidates for anti-cancer drugs. These 
include snake venoms which were shown to exhibit multiple therapeutic effects, despite their toxic 
properties. Snake venoms, which are toxic to most animals, can damage many tissues upon a 
snakebite, such as the central nervous system (Osipov A. and Utkin Y., 2012), the kidneys (Karthik S. 
and Phadke KD., 2004) and the blood (haemorrhage) (Kamiguti AS., 1996). Also, an innate immune 
response can be initiated in which the complement system is activated upon venom injection (Leon 
G., et al., 2011). 
 
Currently, compounds derived from snake venoms are used for multiple therapeutic applications, 
such as drugs for cardiovascular purposes, anti-coagulants (Koh CY., and Kini RM., 2012) and anti- 
cancer drugs (Jain D1, Kumar S., 2012; Selistre-de-Araujo HS., et al., 2010; Markland FS, 2001). In this 
study, anti-malignant properties of snake venoms were tested on pancreatic tumour cells. 
 
Tumourigenesis involves interactions of malignant cells with each other, neighbouring cells and their 
microenvironments, hereby often attracting surrounding vasculature to balance the oxygen supply 
with the demand of a growing tumour. The vascular network is further employed by metastasizing 
cancer cells for their long and short distance traveling to possible secondary metastatic sites. The 
importance to understand and prevent metastasis formation is emphasized by the fact that over 90% 
of all cancer related deaths are due to secondary tumours arising from metastasizing cancer cells 
(Jemal A., 2007). This is especially true for pancreatic cancer types which have a poor prognosis in 85- 
90% of the patients due to metastatic complications (Ganeh P., et al, 2007). 
 
Zebrafish and their transparent embryos have been employed in several useful models for 
therapeutic drug research and preclinical studies (Dooley K. and Zon LI., 2000). High throughput 
screening (HTS) in zebrafish embryos has been established and is nowadays commonly used for 
different applications (Jones KS., et al., 2008; Miscevic F, et al, 2014; Pichler FB., et al., 2003). A 
number of unique features make this animal model very attractive: zebrafish are inexpensive to 
maintain, they breed in large numbers, develop rapidly ex vivo, and can be maintained in small 
volumes of water (Lieschke GJ., and Currie PD., 2007). Recently, the zebrafish and its transparent 
embryos have also come into view as a new model system to investigate tumour development, 




Materials and methods 
 
Animal care and handling 
 
Tg(fli1:eGFP) zebrafish were kept at 28° C in tanks with day/night light cycles of 10 hours dark 
alternated with 14 hours light periods. The zebrafish were handled in compliance with Dutch animal 
care regulations and standard operating procedures. Zebrafish eggs were harvested at two hours 
post fertilization (hpf), followed by incubation at 28° C in egg water (sea salt, 60 µg/ml in tap water). 





The pancreatic cancer cell line (PaTu 8988t) was cultured at a temperature of 370 C and a CO2 
pressure of 5%. The PaTu 8988t cell line was isolated from liver metastases over a decade ago 
(Elsässer H.P., 1992). Their behaviour in an in vitro wound healing assay and in an in vivo zebrafish 
xenotransplantation assay were described in detail before (Marques I., 2009). PaTu 8988t cells were 
cultured in DMEM (Gibco) high glucose supplemented with 10% FCS (Gibco). ZF4 cells are zebrafish 
cells (Driever W., 1993) that were cultured in L15 medium (Gibco) enriched with 15% FCS (Gibco). 
Cells were incubated at 280 C, without CO2 pressure. 
 
In vitro observation of Cytopathic effects and CCID50 (dose that kills half the cells, by observation) 
 
Cells were seeded at a concentration of 104 cells per well in 96 wells plates (Greiner) and 
subsequently incubated at the proper temperature and CO2 saturation. DMEM (Gibco) was used as 
culture medium for PaTu 8988t cells and L15 medium (Gibco) was used for ZF4 cells. Venom was 
dissolved in Hank’s salt solution (Gibco) at a concentration of 2 mg/ml and diluted with to a 
concentration of 0.1 mg/ml. Subsequently, this solution was passed through a 0,2 µm filter. 
Logarithmic venom dilutions of stock solution in PBS were brought onto the cells in the culture 
plates. Plates were then incubated for three days under the conditions mentioned in 2.2. During 
these three days, cells were photographed regularly. A representative set of photos is shown in 
Figure 1 CPE (lysis of the cells, blebbing, pyknosis etc.) was first determined using a microscope 
(Olympus). Data was confirmed with Trypan blue staining of randomized samples. The LD50 was 
calculated using the Reed and Muench method (Reed, L.J.and Muench, H., 1938) as was described 
before for other venoms (Lee K.H. et al., 2006). 
 




PaTu 8990t cells were grown in DMEM (Gibco), supplemented with 10% FCS (Gibco) in 24 well glass- 
bottom culture plates (Invitrosci) and incubated o/n at 37 0C and 5% CO2 saturation. Before the 
addition of snake venom, PaTu 8990t cells were supplied with fresh medium without FCS and 
subsequently a scratch was made using a pipet tip (Eppendorf). A stock solution of 2mg/ml was made 
of the venom in Hanks salts (Gibco), subsequently, this solution was diluted ten times in PBS (Gibco) 
and filtered through a 200 nm filter (Millipore) using a syringe (BD). The highest dose rendered a final 
concentration of 0.5 mg/ml. At a ratio of 1:1 the venom in PBS and medium, the plate was incubated 
at 37 0C and 5%. CO2 saturation until pictures of the scratch were taken under a Leica 
stereomicroscope at different times, shown in Figure 2. The gap was measured and closure was 
calculated in percentage to the initial gap (scratch). 
 
In vitro apoptosis assay 
 
All cell lines were screened for expression of annexin V on apoptotic bodies after exposure of the 
cells to snake venoms, using fluorescently labelled antibodies. Annexin V is detected using a 
fluorescent label: Mitochondrial Membrane Potential Apoptosis Kit, with Mitotracker™ Red & 
Annexin V Alexa Fluor® 488, for flow cytometry (Molecular Probes®). Cells were grown in glass- 
bottom multiwell plates (Invitrosci) until 80% confluence was reached. Cells were washed three times 
in PBS (Gibco, Bleiswijk, Netherlands) before they were incubated with kit components. After 
labelling and analysis, cells were fixed in PFA (Sigma, Zwijndrecht, Netherlands) 4% in PBS, pH 7,4 for 
fifteen minutes, followed by incubation for 1h in the antibody solution containing 0.1% BSA (bovine 
serum albumin) (Sigma, Zwijndrecht, Netherlands) in PBS at a 1:100 dilution. After removal of the 
antibody solution, cells were washed in PBS and incubated for 1h at RT with a fluorescently labelled 
secondary antibody. 
 
Cytotoxicity (Lactate dehydrogenase) 
 
PaTu 8988t cells and ZF4 cells were cultured in 96 wells plates (Greiner) as was indicated in 2.2, 
however, culture media were prepared again without FCS. Cultured cells were incubated with snake 
venoms inducing CPE and subsequent LDH release. The measurement was performed using a LDH 
Cytotoxicity Assay Kit (Pierce Protein Biology Products). The reactions were performed according to 
manufacturer’s protocol. In brief: The LDH released into the medium was transferred to a new plate 
and mixed with reaction Mixture. After a 30 minute room temperature incubation, absorbance was 
measured at 490 nm and 680 nm using a plate-reading spectrophotometer (Tecan) to determine LDH 
activity. Each measurement was done in four-fold. The last two rows of each plated contained 
background- positive- and negative (plain media) controls. Results were statistically analysed using a 




Cell tracker application for in vivo experiments 
 
Cells were plated in 24-well plates (Greiner) at a seeding density of 4,0 *104 cells and incubated for 
 
48 hours at 370 C and 5% CO2. Snake venom dilutions were added, and the cells were incubated again 
at 370 C and 5% CO2 for 24 hours. After detaching the cells with trypsin (Gibco), two washing steps 
were done with DPBS (Dulbecco’s PBS, Gibco), after which the cells were transferred to 1.5 ml 
Eppendorf tubes and centrifuged 5 min, at 1500 rpm. Then, the cells were stained according to 
manufacturer’s protocol after which the cells were suspended in 25μl DPBS for injection into the 
embryos. 
 
Cell transplantation of PaTu 8988t cells into zebrafish embryos 
 
After dechorionation, 2 dpf zebrafish embryos were anesthetised with Tricaine methanesulfonate 
(TMS, MS-222, Sigma). Using a manual injector (Eppendorf, Celltram), the cell suspension was loaded 
into an injection needle (15 μm internal- and 18 μm external diameter (Oxford apparatus) and cells 
were injected in 48 hpf Tg(fli1:eGFP) zebrafish embryos. After injection, the embryos were incubated 
at 35o C and checked for cell presence at 2 hours post transplantation (hpt). Embryos with 
fluorescent cells outside the implantation area at 24 hpt were excluded from further analysis. All 
 
other embryos were incubated at 35o C for analysis during the following days. 
 
Tumour cell-induced angiogenesis 
 
The tumour-cell induced angiogenesis assay was in general performed as was previously described 
(Nicoli S., Presta M., 2007; Nicoli S., Ribatti D., 2007). The 48 hpf zebrafish embryos were 
dechorionated and anesthetised using 0.042 mg/ mL Tricaine (Sigma). Then, the embryos were 
positioned on a 1. 8% agarose dish for injections. Cells were stained as described above, then 
suspended in 20 µl 12. 0 mg / ml Matrigel® solution (Cultrex R Basement Membrane Extract, R&D 
systems, Minneapolis, USA) and kept on ice for a short period until injection. The CellTram Oil 
injector (Eppendorf, Hamburg, Germany) was loaded with an injection capillary (Harvard apparatus) 
which was filled with 5 µl of the cell suspension in Matrigel®, and embryos were injected as 
described in more detail in previous studies (Nicoli S., Protocols 2007; Nicoli S., Cancer Res 
2007;Vlecken and Bagowski, 2009). For statistical analysis, a student t-test was performed which 




Light-microscopy images of pancreatic cells, an MZ16FA stereomicroscope (Leica) and a DFC 420C 
 
camera (Leica) were used. Injected zebrafish embryos (which were incubated in egg-water at 35°C for 
 




1024ES lens (Zeiss) and a Krypton/Argon laser. The data obtained were processed using ImageJ 
software and Photoshop (Adobe). Annexin V labelled cells were analysed using confocal laser 






In vitro venom titration on PaTu 8988t cells and ZF4 cells: Cytopathic effects (CPE) and CCID50 
 
The pancreatic cancer cells and the zebrafish cells were incubated with snake venoms, which induced 
 
CPE (lysis) within 4 hours after application (Figure 1). Viable cell densities decreased the first day 
after which the populations started to grow again. Compared with the untreated control cells, 
treated cell samples were showing significantly more CPE. Also, it can be seen in Figure 1 that there is 
a dose dependent effect in the degree of CPE. As can be seen in photo A: cells treated with a low 
concentration of venom, do not proliferate as one would expect, however, cells shown in D and E 
have proliferated as well or better than the controls. Cells with the highest concentrations of venom 








































Figure 1: CPE titration after venom treatment. PaTu 8988t cells were treated with king cobra venom and a 
Trypan blue stain was done to confirm the results. As is shown, many cells have detached from the wells, 






In vitro migration of pancreatic tumour cells treated with snake venoms. 
 
Venom treated PaTu 8990t cells tend to migrate slower compared to the cells in the control group. 
The latter form already after 24 hours a layer with a confluence of 50% while there is not much 
migration visible at this time in the venom treated cells. However, the amount of CPE, was increased 
in the venom treated cells. The lower doses, shown in the first column, exhibit a delayed migration 
pattern, compared with the control cells. After 96 hours, the lowest dose shows to have reached the 
same level the controls reached after 24 hours. In the medium dose, half of the cells died after 96 
whereas in the highest concentration half of the cells were dead after 60 hours and most of the cells 




Figure 2: Cell migration of PaTu 8990t cells treated with venom of Ophiophagus hannah. Lyophilized O. Hannah 
venom was added to PaTu 8990t cells. In A, D and G 0.1 µg of the venom was added to the cells and in a final 
concentration of 10E-4 the cells were incubated. In B, E and H, the cells were incubated in a final concentration 
of 2.5 X10E-4. In the last column a dilution of 5X10E-4 was maintained. The cells were scored at three different 
times: at 24 hours post infection (24hpi), 60hpi and 98 hpi and the results in time are shown per row. Normal 







Apoptosis caused by snake venom 
 
To investigate whether apoptosis takes place in PaTu 8988t cells after addition of snake venoms 
immunocytochemistry was performed using an Annexin V antibody, a representative selection is 
shown for PaTu 8988t cells in Figure 3. Control cells have intact mitochondria and they lack the 
Annexin V signal (green), whereas cells treated with a low concentration of venom (Second photo, 
D10000) show apoptotic activity. Cells treated with moderate-high concentrations of venom (Third 
photo, D1000) show less apoptotic bodies and lysed mitochondria are visible. In the last photo 
(D100), a high concentration of venom was added and there is no apoptotic activity visible in the 
sample, although mitochondria lysed to a higher degree than is shown in photo C. 
 
Formation of apoptotic bodies is limited to cells infected with moderate and low concentrations of 
snake venoms. Also, the integrity of mitochondria proved to be dependent on the concentration of 
snake venom. Thus, there is a dose related appearance of apoptotic bodies and cell disintegration, 









Figure 3: Apoptosis in cells treated with venom of Ophiophagus hannah (King cobra). Annexin V is shown using 
 
a green fluorescent label while the mitochondria are shown in red Mitotracker™ Red & Annexin V Alexa Fluor® 
 








     
         
         
          


































bodies whereas the lower concentrations venom show apoptosis. The degree of mitochondrial integrity 







Cytotoxicity (Lactate dehydrogenase (LDH)) 
 
Lactate dehydrogenase measurement using PaTu 8988t cells and ZF4 cells treated with snake 
venoms. LDH is an enzyme that is found in damaged tissues in nearly all organisms. It converts 
lactate to pyruvate and vice versa (and NADH to NAD+). LDH is abundant when tissues are damaged 
or, in cell culture, when cells are dying. 
 
We used a colorimetric assay to quantitatively measure lactose dehydrogenase (LDH) released into 
the media from damaged cells as a biomarker for cellular cytotoxicity and cytolysis. An enzymatic 
reaction that results in a red Formazan product can be measured spectrophotometrically. 
As is shown in Figure 4, both cobra venoms do not generate an expected dose dependency, whereas 
viper and king cobra venoms exhibit a response which is dose dependent. Doses with pronounce CPE, 
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Figure 4: LDH (percentages with respect to LDH max = positive control) released by PaTu 8988t cells treated 







The graphs above show LDH production as a reaction on the administered dose of snake venom. In 
the left graph, measurements with spent medium containing king cobra venom can be seen. The plot 
on the right also shows a dose response with spent medium containing venom from the Saw-scaled 
viper. With both venoms dose dependency was observed. For a positive control, three wells with 
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Figure 5: LDH measurements on PaTu 8988t cells treated with snake venoms from Naja species. The graphs 
how LDH production as a reaction on the administered dose of snake venom. In the left graph, measurements 
on spent medium treated with Monocled Cobra venom are shown showing that there is no dose dependency 
observed for these venoms. The plot on the right also shows the results of a dose response experiment on 
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Figure 6: LDH measurements on ZF4 cells treated with snake venoms from different species. In ZF4 cells, the 
venom of O. Hannah generates the expected dose dependent response, whereas the other two (E. carinatus 







Cobra venom exerts anti-metastatic properties on the behaviour of pancreatic cancer cells in vivo 
 
To study the role of the snake venoms in metastatic behaviour, PaTu 8988t cells were treated and 
then labelled with a carbocyanine dye (CM-Dil) and ectopically transplanted in the yolk sac of 2 dpf 
zebrafish embryos of the transgenic zebrafish line, Tg(fli1:eGFP), which express GFP under the fli1 
promoter (an early endothelial marker) and therefore exhibit a green fluorescent vasculature 
(Lawson N.D. and Weinstein B.M., 2002). As a negative control for the venoms, PBS was used. 
 
The results (Figure 6 and Supplemental Table 1) showed that several venoms (e.g. O. Hannah venom 
and E. carinatus venom in this study) have an inhibitory effect on metastatic behaviour, however, not 




significant dose-related effects when applied to the cells. The data obtained in the migration assay in 
vivo differs from the in vitro data. Differences exist due to lack of availability of nutrients and growth 
factors present in an animal. Since no significant effects were observed when cells were treated and 
implanted into the embryo, a different approach was attempted: Embryos were injected with 
untreated cells and the fish with the cells was then soaked in an egg water-venom solution. Other 
venoms that were tested without success were venoms of the copperhead snake and from the 










Figure 7: Anti-metastatic effects of cobra venom on fish with pancreatic cancer cell graft containing PaTu 8988t 
cells. The two control photos show embryos with a transplanted cell mass of which cells have spread via the 
vasculature. The zebrafish embryos that were treated with cobra venom after receiving the cell mass, did not 




Treatment of snake venoms reduces tumour cell-induced angiogenesis 
 
To study tumour angiogenesis in vivo, a method is available that is based on the injection of pro- 
angiogenic mammalian tumour cells into the perivitelline space of zebrafish embryos (Nicoli, S., 
Presta M., 2007). PaTu 8988t were injected into the perivitelline space of zebrafish embryos at 48h 
post-fertilization. These pro-angiogenic tumour cell grafts induced an angiogenic response originating 
 
from the developing sub intestinal-vessels. The results indicate shown in Figure 8 and Supplemental 
 









   
 
 
Figure 8: Anti-angiogenic properties of Cobra venom and Viper venom. The figure shows three confocal 
micrographs of PaTu 8988t cells (red) that were transplanted into 48 hpf fli zebrafish embryos (green). The cells 
were dispersed in Matrigel, because of which they stay ectopically in the embryos yolk. When Cobra venom 
was added to the fish carrying the cells, inhibition of angiogenesis was observed, however, treatment of the 
 
fish with Viper venom resulted in angiogenesis, like the controls. The magnification of the pictures is 20x. (n=20 






Because public demand continues to be strong and the incidence increased, investigation of 
candidate anti-cancer drugs is a part of this study. The studied compounds vary from different snake 
venoms to iridium containing complexes. The compounds that are observed to show an effect are 
followed up with additional experiments. Not only identification of compounds inhibiting malignant 
processes must be addressed but also ways to target the malignancies with these compounds must 
be explored. 
 
Growth inhibition was shown for samples with very low doses, addition of high doses to the egg 
water in which the zebrafish resided, resulted in cell death (for 20 ng and 2 ng of added venom). 
However, the moderately higher doses appeared to induce enhanced proliferation. This 
phenomenon was reported before for venoms from Bothrops species which can activate cytokines 
(Luna K.P.O., et al., 2011; Mora R., et al., 2005) and venom from Echis species can cleave TNF 
(tumour necrosis factor) to its active form for example (VORONOV E., et al., 1999 ). Samples that 
received moderate doses did not differ much from control cells in the number or morphology of the 
cells. There might be some sort of equilibrium and deviating from it, could result in altered behaviour 
of the cells. Cells with high doses snake venom added to them appeared to detach and die. But not 
all of these cells were dead because upon seeding in fresh medium, cell proliferation was resumed. 
Damaging by for example snake venoms is known to bring about more mutations resulting in a 
higher survival rate, therefore prior to experienced trauma the cell and its descendants are not 
identical to the population that has grown after damage. 
 
Apoptosis caused by snake venom was only induced in moderate doses. In higher doses cells almost 
lysed and in the controls, no apoptotic bodies could be discerned. This event could be due to the 
ability of tumour cells to block the apoptotic pathways (Cotter T. G., 2009). The 100x dilution must 
have been far too toxic for the cells to survive, because no apoptosis was observed, whereas 
mitochondrial integrity was clearly lost. Also, nuclei became brighter which also indicates that CPE 
takes place. 
 
Cytotoxicity (LDH) is less severe in ZF4 cells compared to PaTu 8988t cells upon addition of the same 
dose of the same venom. This suggests that untransformed zebrafish cells are more resilient to snake 
venoms than tumour cells. This could be explained by a retention of defence mechanisms in 
untransformed cells that might be able to take action against damage. 
 
Snake venoms were suggested to be effective against metastasis based on the presence of 




Only indications for such an effect were observed when venom from N. naja was added to the fish 
water. Venoms of viperidae (rattlesnake and copperhead snake) did not exert any visible effects in 
any of the experimental settings used here. Snake venoms exhibit inhibitory properties on tumour 
cell-induced angiogenesis. This was only observed using venom of N. naja on PaTu 8988t cells. Viper 
venom slightly reduced the response the vasculature had on the cells, but vasculature was formed. 
Although, it was reported that viper venom contains disintegrins which act against processes such as 
tumour-induced angiogenesis (McLane M.A., et al., 1998; Markland F.S., 1998).
 
Snake venoms contain sometimes exosomes which can easily trigger an immune response in the 
 







The results indicate that, if administered in low concentrations, snake venoms display promising anti- 
malignant properties. However, comparing the results obtained with different venoms it is obvious 
that venoms derived from the cobra species that were tested, did not have a strong impact on PaTu 
8988t cells. Venoms from Ophiophagus hannah and Echis carinatus might be well suited candidate 
cancer inhibitors and will be used for more detailed studies wherein whole venom mixtures as well 
as fractions thereof will be screened. 
 
In vitro obtained data is not interchangeable with data generated in in vivo assays. This underscores 
the aspect that the micro-environment of a living being cannot be imitated precisely in a culture 
flask. The nutrients and other resources which the cells have available in in vivo assays, is not present 
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Supplemental table 1: 
 
Quantitation of embryos showing malignant processes 
 
 
Russels viper total cells out angiogenesis 
0h 20 0 - 





>10 in 6 embryos, 

























>5 in 8 embryos 
 





>20 in 14 embryos, 
>10 in 2 embryos 
 
++ in 12, +/- in 2 embryos 
 
King cobra total cells out angiogenesis 
0h 20 0 - 





>10 in 2 embryos, 
<3 in 2 embryos 
 





















Causal determinants in Pancreatic cancer 
 
In this study, two groups of genes were subjected to analysis. Genes that function in motility were 
assessed as well as genes that function in development were shown to be involved in altering cancer 
cell behaviour. It is obvious that many more groups of genes are potentially involved in tumour 
progression. Other genes have already been identified as key players in cancer. All genes, pathways 
and interactions involved, makes it difficult to predict the patient’s disease profile, and the 
complexity (plus individual differences) makes it even more complicated to generate a custom made 
cure. 
 
The two most important groups of genes participating in tumour genesis and –progression are the 
tumour suppressor genes (loss thereof) and oncogenes (overexpression or constitutive activation 
thereof) (Stan S.D. et al., 2010; Li L. and Leung P.S., 2014). One of these oncogenes is called RAS. In 
pancreatic cancer especially RAS is upregulated which leads to excessive cell division and tumour 
growth in the affected cells. Additionally, the Hedgehog (HH) canonical signalling pathway is 
activated in stromal cells. This results from upregulation of the developmental gene Hedgehog in 
pancreatic cancer. Also, two additional major pathways important in embryonic development, Wnt- 
βcatenin and Notch were found to be upregulated in pancreatic cancer (Morris IV JP. et al., 2010; HH. 
 
Wong and NR. Lemoine, 2009). All genes mentioned above have functions related to migration or 
adherence. 
 
Micro-RNAs are approximately ~22 nucleotides in length. They are processed from hairpin forming 
precursor transcripts and function in posttranscriptional gene silencing by translational repression 
and promotion of target mRNA decay. These molecules were shown to play an important role in 
many malignancies (MiR-10b is important for breast cancer for example and MiR-10a is of 
importance for pancreatic cancer. Targeting these molecules could be feasible strategy to fight 
malignancies. MiR-10a was identified as a facilitating factor repressing HOX B1 and HOX B3. 
Repression of MiR-10a was shown to inhibit metastasis and invasion. (Marques I., et al., 2008; Khan 
S. et al., 2013). If simultaneous retinoic acid receptor antagonists are used, these processes are 
completely abolished. 
 
Malignant disease control 
 
Pancreatic cystic neoplasms are detectable at present day with a biomarker called CEA, on the other 
hand, pancreatic adenocarcinoma is difficult to detect, while this form accounts for 90% of the cases. 
For the only biomarker, CA19-9 which is based on ancillary testing, that is available for early 




bladder, however, this test was reported to be suitable for detection of recurrent adenocarcinoma. 
Pancreatic cystic cancers can be detected when cystic fluid is taken out (Melton S.D. et al., 2010) 
 
Tumour resection is currently a widely used procedure to treat people with malignant, but also with 
metastatic disease. This method is generally accepted because the patient acquires then a survival 





Novel treatments and anti-cancer compounds are being evaluated at present as alternative 
treatments for cancer. One of these concepts was displayed in Chapter 5: biological or organic 
compounds such as snake venoms. Also herbs are currently under investigation and it was reported 
that vegetable and fruits for example are able to have a tumour regress (Stan S.D., et al., 2010; Li L. 
and Leung P.S., 2014; Hendrix M.J.C. et al., 2007) 
 
Recent studies also include assessment of protein trafficking by virus induced nanoparticles into 
human cells (Mangeot PE. et al., 2011). For instance to target medication to a specific structure in the 
human body. As is shown in this work, anti-malignant metal compounds are functional against 
common carcinogenic processes like angiogenesis. However, if such compound would be used by a 
patient without a proper delivery system, the patient’s healthy cells would be the first to die. 
Nanoscale cancer vaccines are in development presently. These contain exosomes which are loaded 
with tumour antigen so that antigen presentation takes place through dendrocytes to effector cells. 
Then NK cells can recognize the tumour by the antigen it expresses, and target it (Tan A. et al., 2012; 
Zeelenberg IS., et al., 2008). On the other hand, exosome signalling was reported to be abundant in 
cancer. Such particle is capable of loading itself with oncogenic cargo in order to empty itself after 




As might have been made clear in this work, most cancers originate from damaged or irritated tissue 
which, over the course of years or decades might adapt to the new (irritable) microenvironment. If 
such cells do not die or are not removed by the organismal defence mechanismsthey will become 
adapted and are able to prosper and ultimately will progress into a malignant tumour. It is widely 
known that nutrition determines physiologic and pathologic processes and recently it was even 
reported that by altering the tumour microenvironment (by changing diet), the tumour could 




cancer studies. In this work I have demonstrated that zebrafish larvae are extremely useful as a model 
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Beïnvloeding van het gedrag van kwaadaardige pancreas cellen 
 
 
De pancreas (alvleesklier) is een orgaan in het abdomen dat bestaat uit een exocrien - en een 
endocrien deel, die verschillende functies hebben. De meest voorkomende vorm van alvleesklier 
kanker is de adenocarcinoom hoewel ook tumoren bestaande uit andere celtypen voorkomen. 
Alvleesklier kanker wordt doorgaans in een laat stadium opgemerkt, zodra lichamelijke klachten zich 
presenteren. Vaak hebben de tumorcellen zich ergens anders in het menselijk lichaam kunnen 
vestigen waar ze tot een nieuwe tumor kunnen uitgroeien. Als de patiënt zich meldt voordat 
metastatische ziekte geïnitieerd is, kan chirurgie een optie zijn. Echter door de complexe 
positionering van de alvleesklier in het abdomen (gedeeltelijk intraperitoneaal, draait om de aorta 
heen) is resectie niet altijd mogelijk. 
 
Cellulaire processen in kwaadaardige tumoren 
 
Voordat er een tumor ontstaat, groeit en zich uitzaait, moet zich eerst een aantal processen in de cel 
voltrokken hebben, voortkomend uit veranderingen (mutaties) in het DNA. Daarna vinden de drie 
hieronder beschreven stappen plaat. 
 
1. Epitheel-mesenchym transitie (EMT): Bij EMT heeft een epitheelcel de vorm aangenomen van een 
mesenchymale cel (Figuur 1). Dit betekent dat de anders zo immobiele epitheelcel los kan breken uit 
het rigide weefsele en op een invasieve manier omliggende structuren kan binnendringen, 
waaronder de bloedbaan. Een transformatie is vaak een lange-termijn proces waarbij er adaptatie 














Figuur 1: Processen die een EMT kenmerken: Een intacte epitheliale laag ondergaat een mutatie waarbij de 
adhesieve kenmerken van de cel aan de basale laag verloren gaan. Hierdoor wordt de cel eerst uit zijn vorm 
gedrukt waardoor hij vervolgens los kan komen uit het epitheel weefsel. Langzaam verandert de cel nu van een 
kubische, vaak gespecialiseerde, in een langerekte cel die in staat is tot migratie, maar hierdoor zijn 
vermenigvuldigings-integriteit en (secretieve) functies verloren is. 
 








2. Zodra er een tumor groeit, moet er, net als bij een orgaan, aanvoer van nutriënten en zuurstof zijn 
en afvoer van afvalstoffen en koolzuurgas. Zolang de tumor nog klein is, kan deze zichzelf van zuurstof 
en nutrienten voorzien door gebruik te maken van diffusie. Maar bij een toegenomen omvang kan er 
zuurstof tekort (hypoxy) optreden in de kern van het tumorweefsel. Hypoxie activeert via een aantal 
door de tumor afgescheiden signaal moleculen de aanleg van vasculatuur (angiogenese). Dit is een 
process waarbij er vanuit bestaande bloed- en lymfevaten, een nieuw vaatstelsel aangelegd wordt, in 
de tumor. Dit proces mag niet verward worden met vascularisatie waarbij er vanuit een enkele 
haemotpoietische stamcel een bloedvat aangelegd wordt. De tumorcellen werden behandeld met 
short interference RNA (si-RNA) en aansluitend werden ze gekleurd. Hierdoor konden de cellen 
gevolgd worden na transplantatie in de perivitelline ruimte van de dooierzak. Voor het angiogenese 
experimentmwerden de cellen voorafgaand aan transplantatie gesuspendeerd in Matrigel ®. Dit is 
een stof die lijkt op de basale laag in weefsels, met als eigenschap dat de cellen erin blijven zitten en 
niet migreren. 
 
3. Op het moment dat er vaten van en naar de tumor zijn aangelegd, kan een van tumorcellen een 
bloedvat binnendringen (intravasatie) en het vervolgens op een andere locatie verlaten (extravasatie). 
Op deze plek kan de cel uitgroeien tot een nieuwe tumor. Deze gebeurtenis wordt aangeduid als 
metastase. Door aanvullende mutaties die de kwaadaardige cellen verworven hebben kunnen ze 
overleven in vreemde of vijandige omstandigheden. Hiervoor moeten cel-cel contacten en cel-matrix 
contacten doorbroken worden in de tumor. De metastaserende cel maakt dan gebruik van de 
aangelegde vasculatuur om door het lichaam te reizen en zich mogelijk elders te vestigen. De 
overlevingskansen van de patient zijn dan aanzienlijk slechter geworden, omdat operatie niet meer 
mogelijk is. Dat betekent dat de patient aangewezen is op andere behandelmethoden. 
 
In deze studie is het gedrag van pancreas-tumorcellen onderzocht om meer zicht te krijgen op de 




gedrag ten gevolge van het uitschakelen van genen bestudeerd. In het tweede deel zijn de effecten 
van diverse experimentele stoffen geanalyseerd op het moment dat ze bij de cellen gevoegd werden. 
 
Genetische veranderingen in kwaadaardige pancreascellen 
 
HOX genen zijn van essentieel belang voor segmentatie en patroonvorming van het lichaam tijdens de 
ontwikkeling van bijna alle dieren. HOX genen hebben vele functies tijdens de embryonale 
ontwikkeling en zijn sterk geconserveerd tussen soorten en in de tijd. De rol die HOX genen spelen in 
metastase en angiogenese van alvleesklier-tumorcellen wordt beschreven in het tweede hoofdstuk. 
Alle 39 HOX genen werden onderzocht door middel van in vitro en in vivo experimenten in zebravis 
embryo's. Niet alle HOX genen leken betrokken te zijn bij metastase en angiogenese. Daarnaast is het 
zo dat Hox genen in staat zijn elkaars functie over te nemen, dit is gebleken doordat uitschakeling 
van meerdere HOX genen resulteerde in gewijzigde mate van metastase en / of angiogenese, terwijl 
uitschakeling van de afzonderlijke genen niet altijd in een effect resulteerde. 
 
In het derde hoofdstuk wordt de invloed van LIM kinase 1 en - 2 onderzocht in alvleesklier- 
tumorcellen, wederom gebruik makende van zowel in vitro als in vivo modelsystemen en platforms. 
Deze assays werden uitgevoerd door LIMK1 en -2 mRNA uit te schakelen met toevoeging van si- 
RNA’s tegen LIMK1 en -2 in de cellen, een dag voor de analyse. De Lim-kinases zijn betrokken bij de 
motiliteit van de cel doordat ze de celspiertjes (actine) kunnen beïnvloeden. Als de Lim-kinases 
uitgeschakeld zijn, doen zich er significant minder maligne processen voor. Als beide tegelijk 
uitgeschakeld werden, konden er geen kenmerken meer ontdekt worden van metastaserende – of 
angiogenese inducerende cellen in de zebravis embryos. 
 
De impact van natuurlijke en synthetische bio-actieve stoffen op het gedrag van alvleesklier tumor 
cellen wordt beschreven in het vierde hoofdstuk. Dit is gebaseerd op een drugs-screen waarbij 
gezocht werd naar mogelijke verbindingen die eerder werden geïmpliceerd een remming te hebben 
in tumor cellen en een effect op angiogenese en vascularisatie. Iridium complexen zijn in staat 
gebleken kwaadaardige processen te remmen binnen hun therapeutische breedte. 
 
Hoewel om van deze verbinding een succesvol geneesmiddel te maken moeten toedieningsroutes 
worden onderworpen aan vervolg- onderzoek. Ook moeten adjuvantia worden geoptimaliseerd of 
moeten ze opnieuw ontworpen worden voor toepassing in de mens. 
 
Het vijfde hoofdstuk geeft meer inzicht in de eigenschappen van slangengif als het toegevoegd 
wordt aan tumorcellen of vissen waarin tumorcellen getransplanteerd zijn. Uit de experimenten die 
werden gedaan wordt duidelijk dat bepaalde slangengiffen (zoals bijvoorbeeld dat van de 




de in vitro en in vivo systemen. Opvallend hierbij is, dat in vergelijking tot de andere 
onderzoeksprojecten, er een afwijkend resultaat ontstond: Als de cellen werden behandeld met een 
gif alvorens transplantatie, werd er geen significant effect waargenomen, maar als de zebravis 
embryos na celtransplantatie in hun water giffen toegediend kregen, werd er wel een effect 
waargenomen. 
 
De conclusie die hieruit getrokken kan worden is dat alvleesklier kanker alleen terug gedrongen kan 
worden als er een drastische verandering van de leefstijl doorgevoerd wordt. Het veranderen van de 
omgeving van de tumor door andere voeding in te nemen, kan resulteren in afname van de 
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